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Investigations Of The Gastrointestinal Tract In Development And Disease
Abstract
The intestine is a highly dynamic organ with diverse functions that are essential for human health, and
disruption of the homeostatic processes involved in intestinal function causes a number of diseases,
such as colorectal cancer, celiac disease, and inflammatory bowel disease (IBD). However, there are still
many gaps in our knowledge of intestinal biology, ranging from the mechanisms of intestinal
development, the signaling networks involved in maintaining intestinal epithelial homeostasis, and the
mechanisms of complex diseases such as IBD. Thus, there is still a lot of work that needs to be done to
better understand the biology of the intestine, which would ultimately benefit intestinal disease research
and therapeutic development.
This thesis contains two distinct studies that address knowledge gaps in intestinal research. First, I
investigated the mechanisms by which the structure of the intestine is refined during embryonic
development, using a conditional genetic ablation mouse model for a critical signaling molecule.
Specifically, FOXL1+ expressing mesenchymal cells, which constitute the sub-epithelial layer of the
intestine from the stomach to the colon, express key components of the Wnt signaling pathway and are
important for maintaining the intestinal stem cell niche in adult mice. Interestingly, these cells also
express WNT5A, a major non-canonical Wnt ligand that is essential for embryonic intestinal development
but whose cell type of action was previously undetermined. For my thesis work, I derived Foxl1-Cre;
Wnt5af/f mice for cell-type specific deletion of Wnt5a solely in epithelium-proximal mesenchymal cells
and assessed the consequences to embryonic development. My results showed that although epithelial
structural integrity was not lost, ablation of WNT5A in FOXL1+ cells is sufficient to cause shortening of
the midgut due to increased epithelial apoptosis during fetal development.
My second project utilized a multiplexed imaging technique called Imaging Mass Cytometry (IMC) to
study the cellular and proteomic profiles of IBD tissues. IBD is a highly heterogeneous disease that leads
to disruption of homeostasis of the immune response, causing chronic inflammation of the intestinal
mucosa. While there are several therapies available for IBD patients, there is still a large unmet need for
those individuals who do not respond to the currently available treatments. Thus, development of novel
therapeutics requires improved disease stratification based on deeper characterization of the inflamed
mucosa. IMC can quantify multiple antigens and cell types of the intestine while maintaining spatial
resolution for assessment of cell-to-cell interactions within disease tissue. I performed multiplexed image
analysis of 12 IBD and 12 healthy control samples, for which I was able to identify and quantify major
immune cell types, their expression markers, and the cell-cell interaction enrichment between regulatory T
cells (Tregs) and other immune cells. This study is an important steppingstone for future spatially
resolved analysis of IBD.
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ABSTRACT

INVESTIGATIONS OF THE GASTROINTESTINAL TRACT IN DEVELOPMENT AND DISEASE
Ayano Kondo
Klaus H. Kaestner

The intestine is a highly dynamic organ with diverse functions that are essential for human
health, and disruption of the homeostatic processes involved in intestinal function causes a number
of diseases, such as colorectal cancer, celiac disease, and inflammatory bowel disease (IBD).
However, there are still many gaps in our knowledge of intestinal biology, ranging from the
mechanisms of intestinal development, the signaling networks involved in maintaining intestinal
epithelial homeostasis, and the mechanisms of complex diseases such as IBD. Thus, there is still
a lot of work that needs to be done to better understand the biology of the intestine, which would
ultimately benefit intestinal disease research and therapeutic development.
This thesis contains two distinct studies that address knowledge gaps in intestinal
research. First, I investigated the mechanisms by which the structure of the intestine is refined
during embryonic development, using a conditional genetic ablation mouse model for a critical
signaling molecule. Specifically, FOXL1+ expressing mesenchymal cells, which constitute the subepithelial layer of the intestine from the stomach to the colon, express key components of the Wnt
signaling pathway and are important for maintaining the intestinal stem cell niche in adult mice.
Interestingly, these cells also express WNT5A, a major non-canonical Wnt ligand that is essential
for embryonic intestinal development but whose cell type of action was previously undetermined.
For my thesis work, I derived Foxl1-Cre; Wnt5af/f mice for cell-type specific deletion of Wnt5a solely
in epithelium-proximal mesenchymal cells and assessed the consequences to embryonic
development. My results showed that although epithelial structural integrity was not lost, ablation
of WNT5A in FOXL1+ cells is sufficient to cause shortening of the midgut due to increased epithelial
apoptosis during fetal development.
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My second project utilized a multiplexed imaging technique called Imaging Mass Cytometry
(IMC) to study the cellular and proteomic profiles of IBD tissues. IBD is a highly heterogeneous
disease that leads to disruption of homeostasis of the immune response, causing chronic
inflammation of the intestinal mucosa. While there are several therapies available for IBD patients,
there is still a large unmet need for those individuals who do not respond to the currently available
treatments. Thus, development of novel therapeutics requires improved disease stratification
based on deeper characterization of the inflamed mucosa. IMC can quantify multiple antigens and
cell types of the intestine while maintaining spatial resolution for assessment of cell-to-cell
interactions within disease tissue. I performed multiplexed image analysis of 12 IBD and 12 healthy
control samples, for which I was able to identify and quantify major immune cell types, their
expression markers, and the cell-cell interaction enrichment between regulatory T cells (Tregs) and
other immune cells. This study is an important steppingstone for future spatially resolved analysis
of IBD.
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CHAPTER 1. INTRODUCTION

Parts of this chapter were adapted with permission from Emerging diverse roles of telocytes. Kondo
A and Kaestner KH. Development (2018) 128, dev175018. doi:10.1242/dev.175018.
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BACKGROUND: INTESTINAL ARCHITECTURE

Adult intestinal biology
The intestine is a highly regenerative organ that is responsible for a multitude of functions,
including water and nutrient absorption, defense against luminal pathogens, and regulation of the
immune response. The intestine is able to perform these diverse functions in homeostasis because
of its highly organized tissue architecture. From a macroscopic level, the intestinal wall itself is
made up of several tissue layers: mucosa, submucosa, muscularis propria, and serosa (Jaladanki
et al., 2011). The mucosal layer contains the epithelium, lamina propria, and muscularis mucosae,
and is located at the innermost side of the gut wall along the lumen. The submucosa lies underneath
the mucosa and consists mainly of lymphatic vessels and nerve fibers; and the muscularis propria
is made up of smooth muscle which regulates the peristaltic movements necessary for mobilizing
food and water through the entire gastrointestinal tract (Montgomery et al., 1999). Finally, the
serosa which contains loose connective tissues is the outermost layer of the gut wall and functions
to protect against frictional movements generated by peristalsis (Jaladanki et al., 2011). Thus, the
tissue layers of the gut wall make the organ conducive to the flexible movements of the organ to
pass ingested food and water down the intestinal tract.
Within the mucosal layer, a single-layered epithelium lies on the luminal-most side of the
of the intestinal wall and is therefore in contact with the external environment. The epithelium is
folded in such a way so that the basal crypts of Lieberkühn (crypts) are embedded in the lamina
propria and the villi protrude out into the intestinal lumen, and these structural units together make
up the crypt-villus axis of the epithelium in the small intestine (Figure 1.1). Importantly, this structure
is only observed in the small intestine, as the colon epithelium only consists of crypts. The epithelial
villi evolved to maximum surface area to drastically increase the water and nutrient absorption rate.
In addition to the villus structures, individual enterocytes develop brush borders characterized by
the formation microvillus along the lumen (Granger & Baker, 1850). With the development of these
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structures, the surface area of the small intestine and colon combined in humans is now estimated
to be about 32m2, about half the size of a badminton court (Helander & Fändriks, 2014).
The epithelium consists of diverse cell types that are also highly organized for achieving
essential metabolic, endocrine, and immune functions. At the base of the crypts are intestinal stem
cells (ISCs), which are marked by their stemness and are able to replenishing the entire epithelial
population every 3-5 days (Barker et al., 2007). This process begins with division and asymmetric
differentiation of the ISCs to give rise to the highly proliferative transit amplifying (TA) cells
positioned along the crypt walls (Barker et al., 2007). TA cells then divide and give rise to the mature
epithelial cell populations, such as the absorptive enterocytes which make up the vast majority of
the intestinal epithelium, and secretory cells including Goblet cells, Paneth cells, Tuft cells, and
enteroendocrine cells. In mice, all mature epithelial cells first appear during embryonic development
and reside along the villus, except Paneth cells which appear postnatally during crypt maturation
and become compartmentalized to the crypt base with the ISCs of the small intestine only (Calvert
& Pothier, 1990; Kim et al., 2012).
Because the epithelium consists of only a single layer of cells, it is vulnerable to tissue
damage and infiltration of external pathogens into the lamina propria. Thus, Goblet cells produce
and secrete mucous into the luminal surface to act as the first barrier of defense against external
pathogens (Noah et al., 2011), and Paneth cells secrete antimicrobial molecules such as Lysozyme
C and defensin (Erlandsen et al., 1974), thereby reinforcing the intestine’s protective capacity. In
summary, the intestinal tissues are highly organized, and this is essential for performing diverse
metabolic and immune functions.

Intestinal stem cell niche
The intestine is regulated by intricate signaling networks between the epithelium and the
surrounding mesenchymal of the lamina propria. In particular, in order for the ISCs to maintain their
undifferentiated and proliferative state, they require constitutive Wnt/beta-catenin signaling
(Wielenga et al., 1999). Also called canonical Wnt signaling, this pathway starts with secretion of a
3

Wnt ligand which then binds to a Frizzled (FZD) receptor expressed on a nearby cell. This activates
a signaling cascade that leads to accumulation of beta-catenin in the cytoplasm followed by betacatenin translocation into the nucleus. There, beta-catenin acts as a transcriptional co-activator of
T-cell factor (TCF) proteins for transcription of proliferative genes such as Cyclin D1 and Axin2
(Staal et al., 2002) (Figure 1.2A). In the case of intestinal stem cells, mesenchymal cells secrete
Wnts non-autonomously to the nearby ISCs to activate this signaling cascade. ISCs highly express
Leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5), which is a receptor for Rspondin ligands that causes internalization of Wnt inhibitors Ring finger protein 43 (RNF43) and
Zinc and ring figure 3 (ZNRF3) upon binding (Morgan et al., 2018). Thus, LGR5 expression on ISCs
acts as an enhancer for canonical Wnt signaling (Yan et al., 2017).
Despite the vital functions of canonical Wnt signaling to the ISCs, for a long time the exact
source of the relevant Wnt signals required to maintain the ISC niche was controversial. In the
small intestine, Paneth cells have been shown to signal to its neighboring ISCs by secreting Wnt3
(Sato et al., 2011). However, two independent studies did not observe changes in ISC proliferation
or maintenance upon ablation of Paneth cells or disrupting their function (Durand et al., 2019; Kim
et al., 2012), challenging the model of the Paneth cells acting as the required source of Wnt signals.
Furthermore, when Wnt signaling coming from epithelial cells was eliminated through the genetic
deletion of the obligatory Wnt-processing enzyme Porcupine (PORCN), the function of the intestinal
stem cell compartment was not impaired (San Roman et al., 2014).
In more recent years, stronger cases have been made for the mesenchymal cells
surrounding the crypts to be the source of Wnt signaling required for maintaining the stem cell
niche. In 2018, the Kaestner lab showed that a rare population of mesenchymal cells, the FOXL1+
subepithelial mesenchymal telocytes (FOXL1+ cells), are an essential source of Wnt signals in the
stem cell compartment (Aoki et al., 2016; Shoshkes-Carmel et al., 2018). FOXL1 is a member of
the Forkhead box (FOX) family of transcription factors, which are evolutionarily conserved in
organisms ranging from yeast to humans (Kaestner et al., 1993). Fox genes control a wide variety
of biological functions and are broadly expressed throughout development and adult life (Golson &
4

Kaestner, 2016). In adult mice, FOXL1+ cells form a thin, continuous plexus underneath the
epithelium (Figure 1.1) and play an active role in the epithelial-mesenchymal cross-talk, expressing
major Wnt signaling, BMP signaling, and Hedgehog signaling molecules. In a 2016 study, cells
expressing FOXL1 were conditionally ablated via cell type specific diphtheria toxin, which led to
cessation of proliferation in ISCs and TAs within three days of FOXL1 ablation (Aoki et al., 2016).
In the subsequent study, Shoshkes-Carmel et al. found that FOXL1+ cells are required for stem cell
maintenance through conditional ablation of Porcn, which led to the elimination of active canonical
Wnt signaling and proliferation in the epithelium within three days (Shoshkes-Carmel et al., 2018).
Around the same time as the FOXL1+ cell discovery, several independent studies provided
additional evidence that the essential Wnt signals and transit amplifying cell proliferation are
produced by the mesenchyme. One study showed that a population of stromal cells expressing
CD34 and PDGFRA provide Wnts and RSPO3 for ISCs (Greicius et al., 2018; Stzepourginski et
al., 2017). This was in concordance with FOXL1+ cells which are a subepithelial subset of
PDGFRA+ stromal cells. Another study showed that the crucial source of Wnt ligands are cells that
express the Hedgehog signaling transcription factor GLI1 (Degirmenci et al., 2018). These GLI1expressing cells are a broader population inclusive of FOXL1+ cells. Epithelial-derived Hedgehog
signaling activates GLI1 in intestinal mesenchymal cells, which in turn binds to an evolutionarily
conserved enhancer to drive Foxl1 gene expression (Madison et al., 2009). Thus, the identification
of FOXL1+ cells in adult mice meant an identification of a more specific subpopulation of
mesenchymal cells that are essential for maintaining the intestinal stem cell niche.

Intestinal development
Much of structural components of the intestine are established during early embryonic
stages; thus, proper development of the intestine is important for the fully mature intestine to
maintain its homeostatic functions. In humans, dysregulation of epithelial structure during
development is implicated in many disorders, including microvillus inclusion disease, very early
onset inflammatory bowel disease (VEO IBD), and leaky gut syndrome. However, there is still a
5

large gap in knowledge regarding the exact mechanisms of intestinal development; specifically, the
midgut elongation process remains one of the least known processes due to the immense number
of signaling pathways involved (Chin et al., 2017). Thus, more research is required to better
understand the intricate signaling networks that are essential for intestinal development.
In mice, the mesoderm and endoderm layers morph into the earliest form of a gut tube by
embryonic (E) day 9.0 (Lewis & Tam, 2006) (Figure 1.3). At E9.5, the endoderm compartment of
the gut tube expressing Caudal type homeobox 2 (CDX2) develops into a single-layered
pseudostratified epithelium that eventually becomes the small intestine (Grosse et al., 2011).
Midgut elongation is initiated at E10 and continues until E14.5, at which point the intestinal epithelial
cells undergo rapid proliferation (Cervantes et al., 2009). Unlike in the adult intestine where
epithelial cell proliferation is regulated by canonical Wnt/beta-catenin signaling, during midgut
elongation the rapid epithelial proliferation is regulated by non-canonical Wnt signaling. This was
shown in mouse studies where deletion of canonical Wnt signaling did not affect intestinal
development before villus formation (Chin et al., 2016).
After midgut elongation, intestinal development enters the vilification stage. This is initiated
by the formation of dense cellular clusters, called mesenchymal clusters, in the lamina propria right
underneath the epithelium at E14.5 (Walton et al., 2012). Mesenchymal clusters express Hedgehog
signaling GLI proteins, as well as Bone morphogenetic protein signaling protein BMP4 and Platelet
derived growth factor receptor alpha (PDGFRA) (Mao et al., 2010; Walton et al., 2012). Hedgehog
signaling is known to be the key pathway in mesenchymal cluster formation and villus elongation,
as studies have shown that ablation of Hedgehog signaling significantly diminishes the ability for
villi to develop (Walton et al., 2012). As villification continues through embryonic development,
epithelial proliferation becomes restricted to the inter-villus regions, and there is a switch from noncanonical Wnt-dependent proliferation to canonical Wnt/beta-catenin dependent proliferation (Chin
et al., 2016). At E16.5, epithelial cells begin to undergo cell differentiation, at which point
enterocytes and the various secretory cell populations emerge (Noah et al., 2011). Paneth cells,
which require Wnt target gene Sox9 for differentiation, do not appear until crypt formation begins
6

postnatally (Noah et al., 2011). In mice specifically, crypts start to form at P5 with invagination of
the intervillus regions into the lamina propria and become morphologically distinguishable from the
villi by P10. Finally, crypts become fully mature by P14, at which point mature Paneth cells have
also differentiated and become localized base of the crypts (Chin et al., 2017) (Figure 1.3).

Epithelial cell polarity and structure
In the study by Shoshkes-Carmel et al., transcriptomic analysis of FOXL1+ cells showed
that these cells are a source of Wnt5a in the small intestine of adult mice (Shoshkes-Carmel et al.,
2018). WNT5A is a secreted protein which functions to activate short-range non-canonical Wnt
signaling in neighboring cells. While canonical Wnt signaling at the crypt base acts on the betacatenin-dependent pathway to sustain active proliferation, non-canonical systems such cell polarity
pathways are beta-catenin-independent and are associated with regulation of structural integrity.
For example, the Drosophila homolog of Wnt5a, wingless, was the first gene of this type to be
identified, where mutants had developmental defects such as loss of segment polarity (Baker,
1987; Cabrera et al., 1987). Mutant flies also displayed defects in epithelial planar cell polarity
(PCP) (Figure 1.2B), which refers to cells’ ability to orient themselves uniformly along the plane of
a tissue, as demonstrated by misorientation of omnatidia of the eyes and dysregulated hair growth
on the wings (Eaton et al., 1996; Strutt et al., 1975).
In vertebrates, WNT5A activates non-canonical Wnt signaling by binding to specific
receptors including ROR2 (Oishi et al., 2003) and Frizzled-5 (FZD5) (Ishikawa et al., 2001), and
activating the downstream effectors JNK, RAC1, and RHOA for cytoskeletal rearrangements
required for cell polarity and migration (Boutros et al., 1998) (Figure 1.2A). Additionally, WNT5A
regulates localization of core PCP proteins such as Vangl1/2 and Prickle1/2 (Gao et al., 2011;
Matsuyama et al., 2009; Minegishi et al., 2017). During development, WNT5A functions in
processes such as tube enclosure and tissue elongation (Habas et al., 2003), and germline deletion
of WNT5A in mice leads to shortening of the limbs, bones, and the intestine (Yamaguchi et al.,
1999). Specifically in the fetal gut, WNT5A is highly expressed in mesenchymal cells surrounding
7

the intestinal epithelium (Yamaguchi et al., 1999), and functions in midgut elongation between
E10.5 and E14 via the apical-basal polarity (ABP) pathway (Cervantes et al., 2009) (Figure 1.2B).
The role of WNT5A in postnatal intestinal development is unknown; however, there are
several key findings that provide strong evidence for WNT5A being a key player in neonatal crypt
formation. First, WNT5A is required for regeneration of new crypts in adult mice after inducing
mechanical injury (Miyoshi et al., 2012). This manipulation promotes upregulation of WNT5A at the
injury site to aid in the regeneration process in wildtype mice; however, mice with conditional
deletion of WNT5A (CAG-CreERT2; Wnt5af/f) develop abnormal crypts. Additionally, the same study
showed that ectopic expression of WNT5A induces crypt-like clefts in colonic organoids (Miyoshi
et al., 2012). Another study found that neonatal crypt formation is impaired in RAC1 conditional null
mice (Villin-CreER; Rac1f/f) (Sumigray et al., 2018).
Thus, WNT5A is essential during development by activating the non-canonical Wnt
signaling pathways for establishing cell polarity and structural integrity. Moreover, the study by
Shoshkes-Carmel et al. showing that FOXL+ cells are localized right next to the epithelium and
express WNT5A suggests that FOXL+ cells may be an important source of WNT5A during intestinal
development.
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BACKGROUND: INFLAMMATORY BOWEL DISEASE

Intestinal regulation of the immune response
The intestinal epithelium is the first line of defense to protect the gut from the billions of
microbes that reside in the intestinal lumen (Liévin-Le Moal & Servin, 2006). Although the
epithelium only consists of a single layer of cells, one of the ways in which they are protected by
the external pathogens is by a thick, mucous layer produced by Goblet cells that lines the entire
gastrointestinal tract. Yet, the immune system still needs a way to gain tolerance to these luminal
microbes so that the immune response does not get activated each time a microbe penetrates the
epithelial barrier. As discussed earlier, the submucosal layer of the gastrointestinal wall is rich in
lymphatic vessels (Jaladanki et al., 2011). Lymph tissues within the gut are collectively known as
gut-associated lymphatic tissues (GALT), and include the mesenteric lymph vessels within the
submucosa and the Peyer’s patches of the mucosa. It is within the Peyer’s patches that immune
cells regulate the immune response, through a process called antigen sampling.
Peyer’s patches are dispersed all along the small intestine just beneath the epithelium. At
the luminal side of Peyer’s patches are specialized epithelial cells called microfold cells (m-cells),
which transport foreign antigens from the lumen into the Peyer’s patch (Owen et al., 1986). Here,
circulating naïve dendritic cells sample the pathogen and present the antigen on its surface via the
major histocompatibility complex (MHC) Class II protein, encoded by the Human Leukocyte
Antigen–DR isotype (HLA-DR) gene (Lelouard et al., 2012). The now activated dendritic cells
activate neighboring naïve CD4+ T helper cells in the Peyer’s patch, which in turn activate the
neighboring naïve CD20+ B cells and CD8+ T cells.
Activation of the T and B lymphocytes causes these cells to gain homing receptors, which
help to guide the cells to migrate from the Peyer’s patches to the lamina propria (Mohamadzadeh
& Luftig, 2004). Importantly, only the T and B lymphocytes that possess T cell receptors specific to
the antigen presented on the MHC II protein of professional antigen presenting cells (APCs) are
activated. Thus, through a process called clonal expansion, the specified T cells and B cells rapidly
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proliferate in the lymph nodes and migrate into the lamina propria (Gitlin et al., 2014). During
migration, activated B cells undergo IgM to IgA class switching and differentiate into plasma cells
that are capable of producing antibodies against the foreign antigen (Mora & von Andrian, 2008).
When the activated T cells reach the lamina propria, some become effector cells that are ready to
eliminate the invaded pathogens, and some become memory cells for long term residence in the
lamina propria, primed to fight against future invasions.
During infection of external pathogens through the epithelial barrier, various immune cells
residing in the gut mucosa work in different ways to fight the invasion. The first to respond are the
innate immune cells, which include macrophages, dendritic cells, neutrophils, and monocytes.
Tissue-resident macrophages engulf the pathogens and present antigens on the cell surface, which
help to activate surrounding T helper cells (CD4+ T cells) and cytotoxic T cells (CD8+ T cells).
Dendritic cells also act as professional antigen presenting cells, and like the antigen sampling
process will travel through the lymphatic vessels to recruit more circulating immune cells to the
infection site. Neutrophils and monocytes normally circulating in the blood are also recruited (Xavier
& Podolsky, 2007).
The adaptive immune response comes into play after the innate immune response. In a
process similar to antigen sampling, APCs from the lamina propria travel through the lymph vessels
to activate and recruit more CD8+ T cells, CD4+ T cells, and plasma cells to the infection site
(Geremia et al., 2014). CD8+ T cells function by secreting cytotoxic enzymes to destroy host cells
infected by pathogens, CD4+ T helper cells activate surrounding inflammatory cells by secreting
pro-inflammatory or anti-inflammatory cytokines. Finally, plasma cells secrete IgA antibodies to
neutralize the pathogens. Thus, the intestine is an essential organ for regulating the immune
response and protecting against external pathogens that may enter the epithelial barrier (Geremia
et al., 2014).
However, under normal circumstances the body is able to prevent an inflammatory
response to microbes that reside in the gut lumen, as well as to ingested food. When dendritic cells
sample these foreign antigens that are not harmful to the body, the protective immune response
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described above is counteracted by an immune tolerance response by regulatory T cells (Tregs),
which are immune cells essential for immunosuppression. Thus, antigen sampling involves a
careful balance of immune protection and immune tolerance responses to achieve intestinal
homeostasis, as loss of homeostasis can lead to overactivation of the immune response. One
disease that is caused by this disruption of homeostasis is inflammatory bowel disease (IBD). The
rest of this chapter will focus on introducing IBD and its etiology, mechanisms of pathogenesis, and
finally the gaps in IBD research pertaining to current therapies and animal models of disease.

IBD epidemiology and pathology
IBD is a chronic, relapsing disease of the gastrointestinal tract. Encompassing both Crohn’s
disease (CD) and ulcerative colitis (UC), the disease affected an estimate of 200-300 per 100,000
people in the United States in 2017 (Alatab et al., 2020). While IBD is more prevalent in western
countries, the prevalence has increased globally from 3.7 million to 6.8 million between 1990 and
2017, and there is currently no cure for the disease. The epidemiological features of CD and UC
are summarized in Table 1.1.
UC onset typically begins within inflammation of the rectum, and disease progression is
indicated by inflammation that moves up the distal colon and in the transverse region in more
severe cases (H. Lee et al., 2016) (Figure 1.4). Inflammation in UC causes ulcerations that erode
away the mucosal layer, leading to formation of macroscopic structures called pseudopolyps
(Geboes, 2003) (Figure 1.4). Although fibrogenesis is a more prominent feature of Crohn’s
disease, a study found that severity of inflammation in UC is associated with a higher risk of
developing fibrogenesis and mucosal thickening (strictures) (Gordon et al., 2018). On the other
hand, in CD inflammation occurs in patches throughout the entire intestine (skip lesions), but
inflammation is most commonly observed in the ileocolonic region (Geboes, 2003). In addition to
strictures, other endoscopic features of CD include fistulas and transmural ulcers affecting the
mucosa, submucosa, muscularis mucosa, subserosa, and mesenteric fat.
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Histopathological assessments can be pivotal for differentiating the diagnosis of CD vs UC.
In UC, inflammation is characterized by presence of plasma cells between the crypt base and
mucosal base (basal plasmacytosis), as well as neutrophil infiltration of the lamina propria and even
the epithelium (cryptitis) (Geboes, 2003). Cryptitis leads to accumulation of dead neutrophils in
epithelial crypts (crypt abscesses). Cytologic features of UC include aberrant presence of Paneth
cells in the colon (Paneth cell metaplasia), as well as mucin depletion from Goblet cells (Elphick &
Mahida, 2005; McCormick et al., 1990). In CD, a key feature that is not observed in UC is the
formation of granulomas, which is caused by aggregation of macrophages, T cells, and other
infiltrates in the lamina propria (Geboes, 2003). Histological features of CD and UC are summarized
in Table 1.2. Despite some of these differences, there are still many overlapping pathological
features of CD and UC; thus the differentiation between the two entities has proven to be
challenging in a clinical setting.

IBD pathogenesis
IBD is a highly complex disease for which the mechanism of pathogenesis remains largely
unknown. However, it is widely accepted to be triggered by a combination of four main factors: (1)
genetic loci for disease susceptibility, (2) overaggressive immune response, (3) environmental
triggers, and (4) luminal microbiome composition (Sartor, 2006). The following sections will
describe these four components of disease pathogenesis.

Genetic risk loci
The involvement of genetics in IBD pathogenesis is evidenced by the fact that family history
is a major risk factor (Khor et al., 2011). A study of monozygotic twins showed that when one twin
had CD, the incidence of the other twin also having CD was 35%, and for UC the incidence rate
was 16% (Spehlmann et al., 2008). This also suggested that incidence of CD is more heavily
influenced by genetic factors than UC. Additionally, genome-wide association studies (GWAS)
have identified 127 genetic risk loci for IBD, with 99 loci specific to either CD or UC, but 28 loci
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overlapping for both diseases (Anderson et al., 2011; Franke et al., 2010). The genes associated
with IBD converge on several common intestinal functions that may be aberrant in IBD patients,
which include barrier function, epithelial wound repair, luminal microbiome, and innate and adaptive
immune responses (Khor et al., 2011), all of which are essential for maintaining intestinal
homeostasis (Table 1.3).
Numerous genes that regulate epithelial barrier and wound repair have been identified by
GWAS. For example, a mutation of the CDH1 gene encoding E-cadherin is implicated in CD, where
the mutation causes E-cadherin to accumulate in the cytoplasm instead of at the cell surface (Muise
et al., 2009), thus disrupting epithelial barrier function. Furthermore, GNA12, a gene for stabilizing
ZO-1 and ZO-2 proteins (Khor et al., 2011; Sabath et al., 2008), as well as PTPN2, which encodes
a protein that protects from IFNg -induced epithelial permeability (Scharl et al., 2009), have also
been identified to be genes associated with IBD risk. Lastly, HNF4A and NKX2-3, which are
important for crypt cell proliferation and intestinal epithelial cell differentiation, respectively,
implicate homeostatic regulation of the intestinal epithelium to be contributors of IBD onset (Cattin
et al., 2009; Darsigny et al., 2009).
IBD is a multifactorial disease; therefore, in most cases genetics alone is not sufficient to
trigger disease onset. However, in some patients diagnosed with very early onset IBD (VEO IBD),
pathology is often indicated by single genetic mutations and the clinical presentations tend to be
severe (Pizarro et al., 2019). Some monogenetic variants have been identified in IL-10RA, STAT3,
TYK2, JAK2, and IL-10 (Glocker et al., 2009; Khor et al., 2011), all of which have been identified
by GWAS and converge on the IL-10R signaling pathway, thereby implicating this pro-inflammatory
pathway to be heavily involved in IBD pathogenesis. Therefore, identification of converging
signaling pathways from these rarer and more severe IBD cases may be pivotal for advancing IBD
research in the future.

Immune response
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During instances of mucosal injury when pathogens penetrate the mucous and epithelial
layer, the innate immune cells such as dendritic cells, macrophages, neutrophils, as well as innate
lymphoid cells (ILCs) activate the protective immune response by secreting pro-inflammatory
cytokines such as IL-1, IL-6, and TNF (Neurath, 2014). In IBD, defects in the innate immune
response include impaired recruitment of immune cells to the infection site. For example, impaired
neutrophil recruitment and decreased interleukin 22 (IL-22) production in the inflamed IBD mucosa
have been observed in CD. IL-22 is a cytokine produced by ILCs and are involved in epithelial
homeostasis and protection, as well as antimicrobial processes (Brand et al., 2006).
Two of the most well-known risk loci identified by GWAS are essential components of
innate immunity. These include mutations of the Nucleotide-binding oligomerization domaincontaining protein 2 (NOD2) and Caspase recruitment domain family member 9 (CARD9) genes.
NOD2 is important for immune response modulation, where deficiency of NOD2 in Paneth cells
causes attenuation of antibacterial activity in intestinal crypts and leads to reduced expression of
defensins, which are important to help fight against bacteria, fungi, and viruses (Shaw et al., 2011).
CARD9 also functions in innate immunity as it regulates cellular apoptosis of pathogen-infected
cells, and a mutation in CARD9 causes the inability to initiate a proper innate immune response
(Hsu et al., 2007).
Another component of the immune response, adaptive immunity, comes into play two
weeks after activation of innate immunity. During adaptive immune response, T cells and B cells
that were activated and recruited by professional antigen cells in the lymph nodes infiltrate the gut
mucosa to eliminate infection. In IBD, observed defects in adaptive immune response involve CD4+
T cells, or T helper cells. T helper cells consist of different subsets: T-helper Type 1 (Th1), T-helper
Type 2 (Th2), and T-helper Type 17 (Th17), and finally Tregs. These cells have unique functions
in the inflamed intestine based on the types of inflammatory cytokines that are secreted.
Specifically, Th1 cells secrete pro-inflammatory cytokines such as IL-1, IL-2, IL-6, IL-12, tumor
necrosis factor alpha (TNFa), and interferon gamma (IFNg) (Neurath, 2014). Th2 cells, on the other
hand, secrete IL-6, IL-9, and IL-13, which promote differentiation and activation of B cells (Neurath,
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2014). Interestingly, CD is implicated to be a disease of overactive Th1 cell activity, whereas UC is
implicated to be due to overactive Th2 cell activity (Tindemans et al., 2020). Additionally, in both
CD and UC, the IL-23/IL-23R signaling axis has been demonstrated to play a large role in IBD
pathogenesis (Duerr et al., 2006). IL-23, which is produced by activated dendritic cells and
macrophages, promotes activation of Th-17 cells. Th-17 cells inhibit Treg differentiation by
production of IL-17, thereby inhibiting Tregs’ role in suppressing the inflammatory response and
contributing to overactivation of effector T cells (Moschen et al., 2019). Thus, the IL-23 signaling
pathway is often considered for IBD therapy, which we discuss later in this chapter.

Environmental factors
Although GWAS studies have revealed the genetic component to be a significant
contributor of IBD pathogenesis, gene alterations alone cannot initiate disease onset and thus
environmental factors also play a major role in IBD. The most well-known environmental factor
contributing to IBD pathogenesis is smoking, where smoking has been shown to exacerbate CD
but protect against UC (Mahid SS, Minor KS, Soto RE, Hornung CA, 2006). Other studies have
implicated environmental factors such as exposure to antibiotics and medications, diet, stress,
sleep, and exercise (Ananthakrishnan, 2015); however, these studies have largely produced
inconclusive results. And just like with genetic factors, environmental factors alone are not sufficient
for triggering disease onset. Thus, further research may be required to gain more clarity into the
various environmental factors contributing to IBD onset and disease severity, using large datasets
to perform meta-data analyses of more diverse cohorts.

Microbiome
The human gut is made up of billions of microbes that help the human body absorb
nutrients and modulate immune responses. Dysregulation of the homeostatic relationship between
the host tissue and the microbiome can lead to intestinal inflammation (Khor et al., 2011); however,
one of the biggest challenges in understanding the role of the microbiome in IBD is identifying which
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species composition and species-specific activity are involved in disease pathology. The human
gut microbiome is unique to each individual where even monozygotic twins only share about 40%
of total composition (Turnbaugh et al., 2010). Thus, the microbiome is influenced by both genetic
and environmental factors, which makes this a challenging field to study in of itself and augments
the complexity of IBD pathology. Numerous studies over the years have only revealed a handful of
microbial species associated with IBD. For example, reduced levels of F. prausnitzii increase the
risk of CD recurrence (Sokol et al., 2008), and increased levels of E.coli promote chronic
inflammation in CD (Khor et al., 2011). Research efforts to identify more bacterial species involved
in IBD pathology will continue to be difficult, but each novel finding will make significant
contributions to improving our understanding of this complex disease.

IBD therapeutics
Years of IBD research have led to development of therapeutics to reduce inflammation, as
well as induce and maintain remission. Currently, there are three main classes of drugs being used
to treat IBD, all of which target the inflammatory immune response: anti-TNF, anti-integrin, and antiIL-12/IL-23 agents (Paramsothy et al., 2018). TNF is a cytokine that increases mucosa permeability
by promoting apoptosis and regulating tight junction proteins; thus overabundance can cause
impaired endothelial barrier, disruption of electrolyte transport, and increase in proinflammatory
cytokines (Kucharzik et al., 2006). Anti-TNF therapies infliximab, adalimumab, golimumab and
certolizumab pegol work effectively to induce remission of inflammation in both CD and UC, and
therefore are most widely used by IBD patients (Neurath, 2017). A second class of therapeutic
agents, anti-integrin, works by inhibiting integrin proteins that are normally required for circulating
leukocytes to migrate to the inflamed intestinal mucosa (Paramsothy et al., 2018). Natalizumab and
vedolizumab are both currently FDA-approved for both CD and UC (Targan et al., 2007), although
onset of this drug tends to be slower than anti-TNF agents. Thirdly, anti-IL-12/IL-23 agents such as
ustekinumab treats CD by inhibiting cytokines IL-12 and IL-23. IL-23 production in the inflamed
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mucosa promotes IL-17 activation to induce a Th1 response (Paramsothy et al., 2018), and
therefore inhibition of IL-23, rather than IL-12, primarily drives the effectiveness of these agents.
Despite these currently available therapies, the rate of induction, remission, and remission
maintenance are widely variable in the aforementioned drug classes and some patients do not
respond to any of these drugs (Paramsothy et al., 2018). Thus, there are still significant unmet
needs for developing novel therapies for these patients. Furthermore, a major gap in the IBD field
is elucidating the mechanisms of action for anti-TNF and anti-IL-12/IL-23 agents (Khor et al., 2011).
For anti-TNF therapies, it is suggested that inhibiting membrane-bound TNF rather than soluble
TNF is contributing more to therapeutic efficacy (Paramsothy et al., 2018), but further studies are
still required to confirm this. For anti-IL-12/IL-23 therapies, IL-23 is a key promoter of IL-17
activation and the Th1 response, making it particularly beneficial for CD patients. Yet, inhibition of
IL-17 was surprisingly shown to have an adverse effect in both human studies and mouse models
of IL-17A neutralization (Hueber et al., 2012; Paramsothy et al., 2018; Targan et al., 2007). This
suggests that IL-23 à IL-17 signaling axis is more complex than just targeting one of these proteins
in therapeutics, and may involve cell-type specific factors. Thus, there is still a gap in knowledge
for understanding the pathways involved in these current therapies and developing novel
therapeutics that are more effective for the subset of patients do not respond to current therapies.

Mouse models of IBD
The advancement of IBD research and the discovery of novel therapeutics are in many
ways attributed to the numerous mouse models developed for preclinical research. Investigations
of spontaneous and induced colitis in these IBD models have shown that defects in epithelial barrier
function and dysregulated immune response are two major contributors of disease (Neurath, 2017).
Dextran sulfate sodium (DSS), trinitro benzene sulfonic acid (TNBS), and oxazolone are
chemically induced models of colitis in mice. DSS is dissolved in drinking water to provoke damage
to the mucosal barrier, which causes acute colitis with symptoms including bloody diarrhea,
ulcerations, and immune cell infiltration (Mähler et al., 1998). TNBS and oxazolone are
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administered by intrarectal instillation to induce damage to the mucosal barrier and activate a Thelper cell-dependent immune response (Neurath, 2017). Both substances are often used as a
method of challenging the mice harboring a genetic mutation and exaggerating the onset of
symptoms to study the mutation. Other mouse models which target the epithelial barrier include
dominant negative mutation of N-cadherin (Hermiston & Gordon, 1995), multiple drug resistant
gene 1 (MDR1) deficiency (Schwab et al., 2003), and deletion of NFKB signaling in epithelial cells
(Nenci et al., 2007). The increased inflammation phenotype observed in these mouse models
demonstrate that epithelial integrity plays a critical role in the onset of IBD, and therefore targeting
epithelial integrity may be of great interest for future IBD therapies.
Mouse models targeting the innate and adaptive immune responses also inform us about
the major signaling pathways involved in colitis. For example, spontaneous colitis is observed in
mice with STAT3 deletion which ablates the IL-10 signaling in myeloid cells (Takeda et al., 1999);
as well as A20 deficiency in mice which inhibits the TNF-NKFB signaling pathway (E. G. Lee et al.,
2000). Because both mice have intact epithelial barrier function, these models showed that colitis
can be induced with just an altered immune response without the epithelial barrier component. For
mouse models targeting the adaptive immune response, overexpression of TNFA (Kontoyiannis et
al., 2002), transfer of CD4+ CD45RBhigh T cells in immunodeficient mice (Asseman et al., 1999),
and STAT4 overexpression to upregulate IL-12/IL-23 signaling (Wirtz et al., 1999) all induce
intestinal inflammation. Furthermore, the type of inflammation seen in these mice are transmural
and therefore is used to model CD.
Despite the significant contributions of these mouse model studies to IBD research, there
are still considerable limitations to non-human subject research because none of the currently
available mouse models accurately predict response to treatment in humans (Pizarro et al., 2019).
Furthermore, even if gene ablations in mice appear to phenocopy colitis observed in IBD, many of
these genetic mutations are not clinically relevant (the genetic alterations in the mouse model are
not observed in IBD patients, or that these mice do not improve after treatment with available IBD
therapies). Finally, the mouse model that is considered to resemble human IBD most closely is the
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SAMP1 mouse line. The phenotype of SAMP1 mice are similar to the clinical features of CD, where
inflammation occurs spontaneously in the terminal ileum and have increased epithelial permeability
(Matsumoto et al., 1998). However, the major setback is that the mechanism of spontaneous colitis
in this model is not known. Therefore, future advancements in IBD research may depend on the
increased use of IBD patient tissues for a more clinically relevant, reverse translational research
approach.
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SPECIFIC AIMS
In this chapter, I introduced crucial topics in intestinal biology and highlighted the
importance of intestinal structural integrity for maintaining homeostatic functions of the intestine.
One aspect of structural integrity that is essential for human health is the ability of the epithelium to
uphold barrier function to prevent pathogenic microbes from entering the lamina propria. Intestinal
structure is directly related to many intestinal diseases such as IBD; thus, there is still a critical
need for a much better understanding of the molecular and cellular pathways involved in intestinal
homeostasis, development, and disease.
In the following chapters of this thesis, I investigate the intestine by two distinct approaches.
In Chapter 2, I determine the contribution of the critical signaling protein WNT5AA produced by a
rare population of FOXL1-expressing mesenchymal cells in intestinal development using a genetic
ablation mouse model. In Chapter 3, I directly address the cellular alterations that occur in human
IBD by performing a multiplexed image analysis using imaging mass cytometry. Thus, this thesis
consists of two studies that are both important but cover distinct areas of intestinal research: (1)
investigation of the mechanisms of intestinal development that help to establish the adult structure
and homeostasis, and (2) investigation of the intestinal mucosal environment in a disease where
intestinal integrity is disrupted.

Aim 1: FOXL1+ mesenchymal cells as a critical source of WNT5A for gut elongation during mouse
embryonic intestinal development.
Functional and regenerative capacities of the intestine rely heavily on the structural integrity
of its epithelial cells. This study investigates the role of FOXL1+ mesenchymal cells during intestinal
development; specifically, it assesses whether FOXL1+ cell-specific ablation of Wnt5a in fetal life
leads to dysregulation of the intestinal epithelial structure and cell polarity using FoxL1-Cre; Wnt5af/f
mice. The significance of this study is that while past functional studies have utilized global deletion
of WNT5A or ectopic treatment of WNT5A in in vitro systems (Gon et al., 2013; Miyoshi et al.,
2012), this is the first in vivo study utilizing a mouse model with a cell type-specific ablation of
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WNT5A. Through this investigation, the chapter emphasizes the importance of utilizing cell-type
specific genetic ablations in mouse model studies for intestinal research.

Aim 2: Highly multiplexed image analysis of intestinal tissue sections of patients with inflammatory
bowel disease.
This study utilizes innovative approaches to characterize the cellular compositions and cell
to cell interactions in human IBD. IBD is a heterogenous and multifactorial disease, with four main
contributors to pathogenesis: immune response, environment, luminal microbiome composition,
and genetic risk loci. These factors together cause dysregulation of epithelial barrier function and
an overaggressive immune response, but the exact mechanisms of pathogenesis remain elusive.
I developed a multiplex image analysis pipeline using imaging mass cytometry (IMC) with an aim
to gain new insights into the pathophysiology of IBD while retaining spatial resolution. Ultimately,
this study using human biopsy samples highlight the power of spatially resolved characterization of
IBD using highly multiplexed antigen detection.

Together, the chapters in this thesis provide broad perspectives on intestinal development
and intestinal disease. The thesis will conclude with a discussion of the challenges and future
perspectives for IBD research.
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TABLES

CD

Factors

UC

Female > Male

Gender

Female = Male

2.1-20 / 100,000 / year

Incidence

2-19 / 100,00 / year

Exacerbates disease

Smoking

Protective factor

15-40 years

Onset

15-40 years

Mainly distal ileum and cecum

Location

Mainly distal colon

Discontinuous, patchy gut
inflammation with skip lesions

Pathology

Continuous inflammatory
lesion, progresses from distal
to proximal

Transmural inflammation
Stenosis, abscess formation,
fistula, colon cancer,
perforation

Histology
Complications

Table 1.1. Epidemiological features of IBD
CD = Crohn’s disease; UC = ulcerative colitis.
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Superficial inflammation
Severe bleeding, toxic
megacolon, rupture of bowel,
colon cancer

Gross features

Rectum, spread proximally

Ulceration patterns

CD
Terminal ileum and
proximal colon most
common
Skip lesions

Ulcer depth

Transmural

Superficial

Stenosis

Observed

Rare

Fistulas and strictures

Observed

Fibrosis

Observed

Microscopic features
Lamina propria cellular
infiltrate
Basal plasmacytosis

CD

Rare
Observed, in advanced
stages
UC

Observed

Observed

Observed

Observed

Crypt distortion

Observed, less common

Observed, more common

Neutrophil infiltration

Observed

Observed

Cryptitis

Observed, less common

Observed, more common

Crypt abscess

Observed, less common

Observed, more common

Crypt destruction

Rare

Observed

Mucosal erosion

Observed, less common

Observed

Mucin depletion

Not observed

Observed

Paneth cell metaplasia

Not observed

Observed

Granulomas

Observed (15-85%)

Not observed

Inflammation onset

UC

Continuous

Table 1.2. Histological characteristics of IBD.
CD = Crohn’s disease; UC = ulcerative colitis. Information obtained from Geboes et. al56.
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Biological
processes

CD

Epithelial barrier

MUC19, ITLN1

Epithelial wound
repair
Paneth cells
Innate mucosal
defense
Innate cell
recruitment
Antigen presentation

Both CD and UC

UC

STAT3

REL, PTGER4,
NKX2-3

GNA12, HNF4A,
CDH1, ERRFI1
ERRFI1, HNF4A,
PLA2G2A/E

ITLN1, NOD2,
ATG16L1

XBP1

NOD2, ITLN1

CARD9, REL

SCL11A1,
FCG42A/B

MST1

IL8RA, IL8RB

CCL11, CCL2,
CCL7, CCL8, CCR6
ERAP2, LNPEP,
DENND1B

IL-23/TH17

STAT3

T-cell regulation

NDFIP1, TAGAP,
IL2RA

B-cell regulation

IL5, IKZF1, BACH2

Immune tolerance

IL27, SBNO2, NOD2

IL23R, JAK2, TYK2,
ICOSLG, TNFSF15
TNFSF8, IL12B,
IL23R, PRDM1,
ICOSLG

IL21
IL2, TNFRSF9,
PIM3, IL7R,
TNFSF8, IFNG
IL7R, IRF5

IL10, CREM

IL1R1, IL1R2

Table 1.3. GWAS-identified risk loci of IBD
Genes associated with epithelial integrity in green; gene associated with innate immune response
in yellow; and genes associated with adaptive immune response in orange. Information from Khor
et. al61.
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FIGURES

Figure 1.1. Schematic of the epithelial crypt-villus axis of the adult small intestine.
At the base of the crypts are the LGR5+ intestinal stem cells and Paneth cells. Transit amplifying
cells lie along the crypt wall; and enterocytes, Goblet cells, Enteroendocrine cells, and Tuft cells
are scattered along the villi. Subepithelial FOXL1+ cells lie underneath the epithelium. Created with
Biorender.com
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Figure 1.2. Canonical and non-canonical Wnt signaling pathways.
(A) The right signaling pathway shows the canonical Wnt/beta-catenin pathway. Here, Wnt binds
to a Frizzled (FZD) receptor which activates Disheveled (DVL), leading to accumulation of betacatenin in the cytoplasm and translocation into the nucleus. In the nucleus, beta-catenin acts as a
co-transcriptional activator of TCF to promote transcription of proliferative genes. The left signaling
pathway depicts the most well-known non-canonical Wnt signaling pathway. A non-canonical Wnt
ligand binds to a FZD receptor, and activates downstream effector DVL, which activates RHOA
and RAC1. Non-canonical Wnt signaling promotes cytoskeletal rearrangements by actin
polymerization. It is also known to activate cJUN-dependent transcription. (B) Diagram depicting
the planar-basal polarity (top), and apical-basal polarity (bottom).
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Figure 1.3. Intestinal development in mice.
At E9.5, the mouse intestine is a single-layered pseudostratified epithelium. Midgut elongation
occurs from E10.5 to E14.5, at which point mesenchymal clusters form in the lamina propria
underneath the epithelium. Villus formation follows starting at E15, and proliferation becomes
localized to the intervillus regions. Crypts form postnatally between P5 and P14. Figure adapted
from Wells and Spence (2014)99.
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Figure 1.4. Inflammation patterns of CD and UC.
Left: In Crohn’s Disease, inflammation appears as skip lesions, where inflamed regions are
scattered along the small intestine and colon. Lesions affect all layers of the intestinal wall, including
the mucosa, sub-mucosa, and muscularis, and are called transmural inflammation. Right: In
ulcerative colitis, inflammation appears as continuous lesions starting from the rectal region and
moving up along the colon. Lesions only affect the mucosa and some of the sub-mucosa and are
called superficial inflammation, but lead to formation of pseudopolyps. Created with Biorender.com.
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CHAPTER 2. FOXL1+ MESENCHYMAL CELLS ARE A CRITICAL SOURCE OF WNT5A FOR
GUT ELONGATION DURING MOUSE EMBRYONIC INTESTINAL DEVELOPMENT

This chapter was adapted from FoxL1+ mesenchymal cells are a critical source of Wnt5a for midgut
elongation during mouse embryonic intestinal development. Kondo A and Kaestner KH. Cells and
Development (2021) 165, 203662, doi.org/10.1016/j.cdev.2021.203662.
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ABSTRACT
WNT5A is a non-canonical Wnt ligand that is essential for normal embryonic development
in mammals. The role of WNT5A in early intestinal development has been examined in gene
ablation models, where Wnt5a-/- mice exhibit strikingly shortened intestines. However, the exact
cellular source of WNT5A has remained elusive, until a recent study found that FOXL1-expressing
mesenchymal cells (FOXL1+ cells), which are localized directly beneath the intestinal epithelium,
express WNT5A. To determine whether FOXL1+ cells are a required source of WNT5A during
intestinal development, we derived Foxl1-Cre; Wnt5af/f mice, which is the first mouse model to
ablate WNT5A in a cell type-specific manner in the intestine in vivo. Our results show that WNT5A
deletion in FOXL1+ cells during fetal life causes a shortened gut phenotype in neonatal mice, and
that our model is sufficient to increase rate of apoptosis in the elongating epithelium, thus explaining
the shortened gut phenotype. However, in contrast to previous studies using Wnt5a null mice, we
did not observe dysregulation of epithelial structure or apical-basal protein localization. Altogether,
our findings establish a developmental role for FOXL1+ mesenchymal cells in controlling noncanonical Wnt signaling during midgut elongation.

39

INTRODUCTION
The mammalian intestine is essential for nutrient and water absorption, defense against
luminal pathogens, and regulation of immune responses. Maintaining structural integrity of the
epithelium is required for the intestine to perform its vital functions, and dysregulation of epithelial
structure is associated with human diseases such as inflammatory bowel disease, and
developmental diseases such microvillus inclusion disease.
In mice, much of intestinal development occurs during fetal life. Between embryonic day
(E) 10.5 and E14.5, the midgut undergoes a dramatic elongation process, at which point the
epithelium is pseudostratified (Grosse et al., 2011). Initiation of villus formation occurs around
E14.5 (Walton et al., 2016), and intestinal crypts develop postnatally between postnatal day (P) 4
and P14 (Chin et al., 2017). In adults, the fully developed intestine consists of a single layer of
columnar epithelial cells with mature crypts embedded in the lamina propria, and villi protruding
into the intestinal lumen. At the base of the crypts are LGR5+ intestinal stem cells (ISCs), which
divide and produce transit amplifying (TA) cells. TA cells rapidly proliferate and differentiate to give
rise to secretory cells and absorptive enterocytes, which together constitute the epithelial cells of
the villi.
The ISCs reside in an environment called the intestinal stem cell niche, where constitutive
Wnt/beta-catenin (canonical Wnt) signaling allows stem cells to maintain their undifferentiated and
proliferative state (Staal et al., 2002; Wielenga et al., 1999), and recent findings have shown that
essential Wnt signaling is provided by the surrounding mesenchymal cells (Aoki et al., 2016;
Degirmenci et al., 2018; Greicius et al., 2018; Shoshkes-Carmel et al., 2018; Stzepourginski et al.,
2017). FOXL1-expressing mesenchymal cells with telocyte properties (FOXL1+ cells) are localized
directly beneath the adult intestinal epithelium, separated from epithelial cells solely by the
basement membrane (Aoki et al., 2016; Shoshkes-Carmel et al., 2018). Notably, ablation of
porcupine (PORCN), a protein required for maturation of all Wnt proteins, in FOXL1+ cells of adult
mice causes complete cessation of canonical Wnt signaling to intestinal stem cells (Shoshkes-
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Carmel et al., 2018). This was an important discovery that showed that FOXL1+ cells are critical for
canonical Wnt signaling in the intestinal stem cell niche.
FOXL1 is a transcription factor most highly expressed in the gastric and intestinal mesoderm of
mouse embryos (Kaestner et al., 1996), and ablation of this gene causes a delay in fetal intestinal
development (Kaestner et al., 1997). Foxl1 transcription is regulated by binding of GLI proteins, a
major component of the Hedgehog signaling pathway, to cis-regulatory elements of Foxl1
(Coquenlorge et al., 2019; Madison et al., 2009). FOXL1 is initially expressed in mouse embryos
at E8.5, where it is localized to mesenchymal cells surrounding the gut tube. Expression becomes
restricted to the most subepithelial region of the lamina propria later in embryonic development
(Kaestner et al., 1996). These early studies suggested that epithelial cells are involved in a crosstalk with the surrounding mesenchyme to regulate proliferation and differentiation during
development.
FOXL1+ cells in adult mice were found to express WNT5A (Shoshkes-Carmel et al., 2018),
which functions in short-range non-canonical Wnt signaling to neighboring cells. Unlike the
canonical Wnt signaling pathway, non-canonical Wnt signaling is beta-catenin-independent
(Slusarski et al., 1997), and is important for establishing cell polarity (Gao et al., 2011; Gon et al.,
2013; Qian et al., 2007). In vertebrates, WNT5A is required for tissue elongation during organ
development, as Wnt5a-/- (WNT5A null) mice exhibit shortened tail, snout, limbs and bones
(Yamaguchi et al., 1999). The role of WNT5A during early intestinal development has also been
examined in WNT5A null mice, which exhibit shortened intestines by E18.5 (Cervantes et al., 2009;
Matsuyama et al., 2009; Wang et al., 2018). However, the cellular source of WNT5A required for
intestinal elongation has not been determined. Therefore, we derived Foxl1-Cre; Wnt5af/f mice to
elucidate the function of WNT5A in FOXL1+ cells. We show that deletion of WNT5A in FOXL1+ cells
causes increased apoptosis in epithelial cells at E12.5, resulting in shortened intestines at birth. In
contrast to some previously published studies, which suggested that apical-basal polarity is
dysregulated in WNT5A null mice, we found intact epithelial cell polarity in Foxl1-Cre; Wnt5af/f mice.
We conclude that FOXL1+ cells are a critical source of WNT5A during midgut elongation. To our
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knowledge, this is the first study to characterize a specific mesenchymal cell population sustaining
WNT5A production during embryonic intestinal development.
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MATERIALS AND METHODS

Mice
All procedures involving mice were conducted in accordance with approved Institutional
Animal Care and Use Committee protocols. Foxl1-Cre mice were generated in the Kaestner Lab
(Sackett et al., 2007), and Wnt5af/f mice were procured from The Jackson Laboratory (B6;129SWnt5atm1.1Krvl/J) (Ryu et al., 2013). Genotyping of the two mouse lines were performed using the
following primers: Foxl1-Cre F: GCG GCA TGG TGC AAG TTG AAT and R: CGC CGC ATA ACC
AGT GAA ACA; Wnt5a F: GGT GAG GGA CTG GAA GTT GC and R: GGA GCA GAT GTT TAT
TGC CTT C.

RNA isolation and qRT-PCR
To perform qRT-PCR, we first isolated RNA from dissected gut tubes. For P0 samples, we
measured 4 cm of the small intestine proximal from the cecum, washed the tissue with cold 1X
PBS, and homogenized the tissue in TRIzol reagent (Invitrogen). For E12.5 and E14.5 samples,
we homogenized the whole gut in TRIzol. The homogenized tissues were either used immediately
for RNA isolation or stored in -80ºC for later experiments. Total RNA was isolated using the RNeasy
Mini kit for P0, and the RNeasy Micro kit for E12.5 and E14.5 (Qiagen), and cDNA was synthesized
using Superscript II Reverse Transcriptase (ThermoFisher). qRT-PCR was performed using
Brilliant III Ultra-Fast SYBR Green qPCR Master Mix kit (Agilent Technologies). For quantifying
Wnt5a gene expression, primer sets were designed flanking Exon 2 (F: GGT GCC ATG TCT TCC
AAG TTC and R: CCG GAA CTG GTA CTG GCA TT). Actin primer sets were used for expression
normalization (F: CCT TCT TGG GTA TGG AAT CCT G, and R: TGG CAT AGA GGT CTT TAC
GGA), and relative expression was calculated using the ΔΔCT method.

Tissue preparation for immunohistochemistry
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E12.5, E14.5, and P0 tissue samples were prepared for paraffin-embedded
immunohistochemical analyses. For E12.5, the embryos were euthanized by decapitation, briefly
washed in cold 1X PBS, and fixed in 4% paraformaldehyde overnight in 4ºC. For E14.5 and P0
samples, intestines were dissected and washed briefly in cold 1X PBS, and fixed overnight in 4%
paraformaldehyde in 4ºC. The next day, all tissues were rinsed in 1X PBS for 2 x 1 hour, then
dehydrated in 70% ethanol for 4 hours, 95% ethanol for 2 x 3 hours, and 100% ethanol for 2 x 1
hour, and embedded in paraffin. Paraffin blocks were cut into 5 µm thick sections and were stored
at room temperature until use.

Immunostaining and antibodies
Sections were deparaffinized in xylene and rehydrated in ethanol, and washed in 1X PBS
for 5 min, followed by 1X PBS-T (0.25% Triton x-100) for 15 min, and 1X PBS for 3 x 5 min. Antigen
retrieval was performed using a Tris-EDTA antigen retrieval buffer (pH 9.0). Sections were
incubated for 30 min in Cas block buffer (Life Technologies) and incubated with primary antibodies
overnight in 4ºC. The following day, the sections were washed 3 x 5 min. in 1X PBS, incubated with
secondary antibodies for 2 hours at room temperature, then washed and counterstained with
Hoechst (Invitrogen) before imaging. The following antibodies were used for this study: FoxL1
(made in-house, 1:1500) E-cadherin (BD Bioscience, cat. 610181, 1:300), EpCAM (Abcam, 1:300),
Ezrin (Cell Signaling, 1:300), zona occludens 1 (ThermoFisher, 1:200), atypical Phosphokinase C
(Santa Cruz Biotechnology, 1:200), Laminin (Abcam, 1:300), phospho-histone H3 (BMD millipore,
1:300), and Ki67 (BD Pharmagen, 1:300). All stained sections were imaged on a Leica TCS SP8
Confocal for immunofluorescence, and a Keyence BZ-X8100 microscope for brightfield imaging.

FOXL1 immunostaining
Immunohistochemical staining for FOXL1 was performed using the antibodies described
previously (Aoki et al., 2016). Briefly, sections were deparaffinized in xylene and rehydrated in
ethanol, and washed in 1X PBS for 5 min, followed by 1X PBS-T (0.25% Triton x-100) for 15 min.
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Antigen retrieval was performed using a Tris-EDTA antigen retrieval buffer (pH 9.0), quenched for
15 min with 3% hydrogen peroxide, blocked in Cas block buffer (Life Technologies) for 1 hour, and
incubated overnight with primary antibodies in 4ºC. The following day, the sections were incubated
with Avidin and Biotin (Vector Labs) and incubated with biotinylated guinea pig IgG antibodies
(Fisher Scientific, 1:300) for 30 min. Amplification was performed by incubation with streptavidinperoxidase conjugate (Akoya followed by incubation of the sections with Alexa 647 conjugated to
streptavidin, and finally washed and counterstained with Hoechst (Invitrogen) before imaging.

Cell death detection
Apoptosis assay was performed using the ‘In Situ Cell Death Detection Kit’ (Millipore
Sigma). Briefly, tissue sections were dewaxed using Xylene and ethanol gradients, and washed
with 1X PBS. The sections were pre-treated with Proteinase K, washed with PBS, then incubated
with TUNEL reaction mixture for 60 min in 37ºC. The slides were washed with PBS and
counterstained with Hoechst before imaging as described above.

In situ hybridization
In situ hybridization on E12.5, E14.5, and P0 gut sections were performed using the
RNAscope 2.5 LS Duplex Reagent Kit for the Leica Bond Rx (ACDBio), using commercially
available Wnt5a and Foxl1 probes (ACDBio). The procedure was performed by the Pathology Core
at the Children’s Hospital of Philadelphia using a Leica Bond Autostainer.

Statistical analysis
All statistical analyses were performed using the Prism software (GraphPad, version 8.2.1).
Statistical significance was calculated using Mann-Whitney test for comparing ranks.
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RESULTS

FOXL1 and WNT5A are partially co-expressed in developing intestine.
WNT5A is an essential developmental protein that is expressed in the intestinal
mesenchyme from embryonic stages into adulthood (Gregorieff et al., 2005; Lickert et al., 2001).
In the adult mouse intestine, WNT5A has been shown to be expressed in FOXL1+ cells, along with
other key Wnt signaling ligands and receptors (Shoshkes-Carmel et al., 2018). However, up to now,
the extent to which FOXL1 and WNT5A are co-expressed during fetal development had not been
characterized. Therefore, to determine whether FOXL1+ cell-derived WNT5A is essential for
intestinal development, we first set out to assess co-expression of WNT5A and FOXL1 in the
midgut mesenchyme. We performed in situ hybridization for detection of Foxl1 and Wnt5a mRNAs
in wildtype mice at E12.5, E14.5, and P0 (Figure 2.1A-C). To validate nuclear localization of FOXL1
proteins in the subepithelial mesenchyme of the developing gut, we also performed
immunofluorescent staining for FOXL1 (Figure 2.1D-F). At all three developmental stages FOXL1
expression was restricted to the intestinal subepithelial regions, as previously reported (Aoki et al.,
2016; Kaestner et al., 1996; Shoshkes-Carmel et al., 2018). On the other hand, Wnt5a was more
broadly expressed in the intestinal mesenchyme at E12.5 and E14.5, and only became restricted
to the subepithelium in later embryonic stages, which is evident at P0. Finally, to determine the
function of WNT5A produced by FOXL1+ cells, we derived Foxl1-Cre; Wnt5af/f mice (‘mutant’
throughout) (Figure 2.1G). This mouse model utilizes Cre-mediated deletion of exon 2 at the Wnt5a
gene locus, resulting in an early truncation mutation (Ryu et al., 2013). We performed qRT-PCR to
confirm reduced expression of Wnt5a in mutant mice compared to control mice (Figure 2.1H). We
did not expect to see complete ablation of Wnt5a expression in our model based on mRNA
localization patterns, where Wnt5a is more broadly expressed than Foxl1 (Figure 2.1A-C).
However, because FOXL1+ cells lie directly adjacent to the epithelium, these cells have the
potential to play a more critical role in epithelial-mesenchymal crosstalk mediated by short-range
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Wnt signaling more than other WNT5A-expressing cells. Therefore, we set out to further assess
the functional role of FOXL1+ cell-derived WNT5A.

Foxl1-Cre; Wnt5af/f mice have shorter intestines at birth compared to littermate controls.
WNT5A null mice present with severe developmental defects, including stunted skeleton,
limbs, digits, and snout, demonstrating that WNT5A is required for elongation of organs that require
proximal to distal outgrowth (Yamaguchi et al., 1999). To assess the extent to which FOXL1+ cellderived WNT5A recapitulates the null mouse phenotype, we measured body weight, body length,
tail length, and hindlimb length of Foxl1-Cre; Wnt5af/f mice at birth (P0) (Figure 2.2). While the
mutants displayed a lower body weight compared to their littermate controls (Figure 2.2A), we did
not detect stunted growth of body, tail, and hindlimb (Figure 2.2B-D), confirming that our mutant
mice had no developmental defects of non-intestinal organs. We hypothesized that the difference
in weight was caused by intestinal defects in neonatal mutant mice. Therefore, we measured
intestinal lengths of mice at P0 and found mutant small intestines to be significantly shorter than
those of littermate controls (Figure 2.2E,F). However, the shortened gut phenotype was not as
severe as what has been reported in WNT5A null mice (Cervantes et al., 2009). Nevertheless, our
model showed that while FOXL1+ cells are not the only source of WNT5A in the intestinal
mesenchyme, these cells produce WNT5A that is necessary for proper midgut elongation during
intestinal development.

Foxl1-Cre; Wnt5af/f mice have normal epithelial architecture and apical-basal polarity.
WNT5A is a non-canonical Wnt ligand, and so its action is independent of b-catenin. In
canonical Wnt signaling, its activation causes accumulation of b-catenin in the target cell’s
cytoplasm, which leads to its translocation into the nucleus. There, b-catenin acts as a signaling
co-activator to TCF and LEF transcription factors to aid in transcription of cell cycle genes (Staal et
al., 2002). Non-canonical Wnt signaling acts via several cytoplasmic effectors, where WNT5A
binding to specific receptors such as ROR2 (Oishi et al., 2003) and Frizzled-5 (FZD5) (Ishikawa et
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al., 2001) activates the downstream effectors JNK, RAC1, and RHOA(Boutros et al., 1998).
Although proteins such as cJUN and NFAT are known to be involved in downstream transcriptional
activation (Dejmek et al., 2006), non-canonical signaling involves signaling cascades that are nontranscriptional to regulate the planar cell polarity and apical-basal polarity pathways (Gao et al.,
2011; Matsuyama et al., 2009). Cell polarity refers to a cell’s ability to orient itself along the plane
of the tissue. In the gut, apical-basal polarity pathways regulate the epithelial cells’ ability to orient
themselves between the apical (luminal) and basal sides, thus allowing the epithelium to endure
the dynamic changes of the intestine during development while maintaining structural integrity.
Previous studies have suggested that whole body WNT5A deletion leads to abnormal epithelial
structure during the pseudostratified epithelial stage, when the gut is elongating between E10.5
and E14.5 (Matsuyama et al., 2009). H&E staining of our mutant mice at E12.5, E14.5 and P0
showed no abnormal epithelial structure compared to control mice. (Figure 2.3).
Next, we performed immunofluorescent staining to determine whether apical-basal polarity
was dysregulated in our mice (Figure 2.4, Figure 2.5). Atypical phosphokinase C (aPKC), ZO-1,
and Ezrin are all markers of apical polarity and are expressed exclusively on the luminal side of the
intestinal epithelium. aPKC and ZO-1 are proteins involved in the formation of tight junctions
(Giepmans & Moolenaar, 1998; Suzuki et al., 2001), and Ezrin is a protein that is required for
formation of microvilli during development (Vaheri et al., 1997). By visualizing localization of these
three proteins by immunofluorescent staining, we could assess apical-basal polarity via three
structural components that define epithelial structural integrity (Figure 2.4A-F, Figure 2.5A-L).
Furthermore, we assessed localization of laminin, which is a basal membrane protein marker
involved in the establishment of apical-basal polarity (Figure 2.4G-L) (Cervantes et al., 2009;
O’Brien et al., 2001). However, we did not observe any dysregulation of these apical and basal
polarity proteins at E12.5, E14.5, and P0. Therefore, we conclude that the short-gut phenotype in
Foxl1-Cre; Wnt5af/f mice is not due to dysregulation of epithelial cell polarity.
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Foxl1-Cre; Wnt5af/f mice have normal epithelial proliferation but have increased apoptosis
at E12.5.
To identify the mechanisms by which WNT5A deletion in FOXL1+ cells causes gut
shortening, we next assessed the rate of proliferation of intestinal epithelial cells, which rapidly
proliferate during midgut elongation. Immunofluorescent staining for Ki67 at E12.5 and P0 showed
that the epithelial cells of WNT5A deleted mice do not have decreased proliferation (Figure 2.6).
Because Ki67 is present in cells that are in any active phase of the cell cycle, it is challenging to
quantify rate of proliferation at E12.5 using the Ki67 marker. Therefore, we stained for
phosphorylated histone H3 (pHH3), which only detects mitotically active cells (Figure 2.7) (Kim et
al., 2017). For E12.5 intestines, we quantified the relative rate of proliferation by counting the
number of pHH3-positive cells in the epithelium, divided by the area of the epithelium (in pixels) in
the image (Figure 2.7C). For P0 samples, we quantified the rate of proliferation by dividing the total
number of pHH3-positive cells by the number of intervillus regions in the image (Figure 2.7F).
Using this method, we found no significant changes in the rate of proliferation between WNT5A
deleted mice and control mice at E12.5 and P0. This was an expected finding for mice at E12.5, as
previous studies have shown that WNT5A and non-canonical signaling do not affect proliferation
during early embryonic stages (Wang et al., 2018). However, the role of WNT5A in regulating
proliferation in neonatal mice was not known up to this point, as all previous WNT5A functional
studies in the intestine used WNT5A null mice, which are perinatal lethal (Yamaguchi et al., 1999).
Our assessment reveals that WNT5A deletion from FOXL1+ cells does not affect epithelial
proliferation at birth, a critical time when the gut is priming for postnatal crypt development.
Finally, in WNT5A null mice, gut shortening has been shown to be caused by an increase
in apoptotic activity in epithelial cells, leading to increased shedding of apoptotic cells into the
intestinal lumen (Wang et al., 2018). To determine whether gut shortening in our model is caused
by increased apoptotic activity, we performed in situ cell death detection by TUNEL staining, which
labels double strand breaks in the DNA (Kyrylkova et al., 2012). We determined the rate of
apoptosis in the epithelium using the same quantification methods described in section 3.4, and
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detected a significant increase in epithelial cell apoptosis in mutant mice at E12.5 (Figure 2.8A-C).
Rates of apoptosis at P0 on the other hand were indistinguishable between the two groups (Figure
2.8D-F). In sum, we conclude that WNT5A production by FOXL1+ cells is required for midgut
elongation, and loss of WNT5A production by these cells causes a shortened intestine by
increasing epithelial apoptosis.
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DISCUSSION
Our study shows that when WNT5A is ablated from FOXL1-expressing mesenchymal cells,
epithelial cells undergo increased apoptotic activity during midgut elongation, resulting in shorter
intestines at birth. To the best of our knowledge, this is the first study to successfully identify a
specific mesenchymal cell population to be an important source of WNT5A during embryonic gut
development. In addition to the WNT5A null model, previous studies utilized more broadly
expressed markers for WNT5A ablation in the intestine such as ubiquitously expressed Cag-Cre
(Miyoshi et al., 2012), or modeled gut shortening phenotype by ablating the WNT5A receptor ROR2
(Yamada et al., 2010), and its antagonists SFRP1 and GPC6 (Matsuyama et al., 2009; Shi et al.,
2020). While it has been known for some time that WNT5A is produced in the intestinal
mesenchyme, we showed that deleting WNT5A from FOXL1+ subepithelial cells leads to an
alleviated form of the WNT5A null phenotype.
Our experiments in Figure 1 show that while Wnt5a and Foxl1 are co-localized in the
mesenchymal cells directly beneath the epithelium, during early intestinal development Wnt5a is
more broadly expressed in the mesenchyme than Foxl1. With this knowledge, we expected that
the gut shortening phenotype would be milder than what is observed WNT5A null mice. In fact,
WNT5A null mice have almost an 80% reduction of small intestinal length compared to wildtype
gut (Yamaguchi et al., 1999), while Foxl1-Cre; Wnt5af/f mice display only a 15% reduction in length
(Figure 2.2E-G). Furthermore, the body, tail, and limbs of WNT5A null mice are significantly
truncated at E18.5, which demonstrates the importance of WNT5A in the development of numerous
organs (Yamaguchi et al., 1999). By contrast, we did not observe any changes in body, tail, and
hindlimb lengths in the Foxl1-Cre; Wnt5af/f mice (Figure 2.2B-D). This raises concerns about
potential consequences of global null models when studying gene function. In this particular case,
we are left to wonder whether the significant shortening of the intestines in WNT5A null mice is
largely contributed by the overall stunted growth of the animal. A future functional study using a
WNT5A deletion model that only targets the intestinal mesenchyme, such as with a Pdgfra-Cre
driver, may be useful to uncover additional functions for WNT5A in gut development.
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In early embryonic stages, WNT5A is required to establish planar cell polarity by polarization of
node cells for breaking of left-right symmetry (Minegishi et al., 2017), while in intestinal
development WNT5A is associated with apical-basal polarity. However, studies have presented
conflicting conclusions with respect to whether apical-basal polarity is dysregulated in WNT5A null
mice, where some claim that WNT5A is regulates apical-basal polarity protein localization and is
thus required for cell polarity establishment in the intestine (Matsuyama et al., 2009), while others
claim that WNT5A is not involved in this process (Cervantes et al., 2009; Wang et al., 2018). The
disparities in the role of WNT5A in establishing cell polarity in the intestine reflect the challenges of
studying non-canonical Wnt signaling pathways, which involve numerous ligands, receptors, and
downstream effector proteins. Furthermore, the mechanism of protein rearrangements in the
cytoplasm required for establishing cell polarity are largely non-transcriptional and therefore remain
elusive. Yet, with the acknowledgement that the Foxl1-Cre; Wnt5af/f mouse model ablates WNT5A
only from a subset of mesenchymal cells during development, our findings support previous
observations that WNT5A does not regulate apical-basal cell polarity, as evidenced by normal
epithelial structural integrity and polarity protein localization at E12.5, E14.5, and P0 (Figure 2.3,
Figure 2.4, Figure 2.5).
In conclusion, we have identified FOXL1+ mesenchymal cells as a source of WNT5A during
midgut elongation, where we observed shortened intestines in Foxl1-Cre; Wnt5af/f mice compared
to littermate controls. The increase in apoptosis observed in the mutant mice suggests that cause
of intestinal shortening is due to increased epithelial cell death during midgut elongation and is
independent of apical-basal polarity protein localization. This is the first study to identify a
mesenchymal cell type contributing to the secretion of WNT5A from the mesenchyme to regulate
intestinal development. With our findings we hope emphasize the importance of performing
functional studies using cell-type specific gene ablation models to eliminate confounding effects of
global gene deletion.
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FIGURES

Figure 2.1. Validation of WNT5A and FOXL1 co-localization in mouse intestines
(A-C) In situ hybridization of Foxl1 and Wnt5a in wildtype mice using RNAscope shows Foxl1
mRNA localized to the subepithelium, while Wnt5a is expressed more broadly in the intestinal
mesenchyme at E12.5 and E14.5. At P0, Wnt5a becomes localized to the subepithelial intervillus
regions (asterisks). (D-F) Immunohistochemical staining for FOXL1 shows nuclear expression in
subepithelial regions of the intestine at E12.5, E14.5, and P0. (G) Schematic for the Foxl1-Cre;
Wnt5af/f mouse model. (H) Quantification of Wnt5a mRNA levels in Foxl1-Cre; Wnt5af/f and control
mice shows decreased expression in experimental mice. (*) indicates p value < 0.05, (**) indicates
p-value < 0.01.

53

Figure 2.2. Physical assessment of mutant mice at P0
(A) Compared to control mice, mutant mice have reduced body weight at birth, but normal (B) body
length, (C) hindlimb length, and (D) tail length. (E) Quantification of gut length in mutant and control
mice at P0. (F) Representative images of control (top) and mutant (bottom) mouse intestines at
P0. (***) indicates p-value < 0.001, (ns) indicates no significance.
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Figure 2.3. H&E images of the developing gut
Foxl1-Cre; Wnt5af/f mice have epithelial architecture comparable to the controls at (A,D) E12.5, and
(B,E) E14.5, and (C,F) P0.
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Figure 2.4. Immunofluorescent staining for aPKC and Laminin
(A-F) aPKC is an apical polarity protein and marks the luminal side of the epithelium. (G-L) Laminin
is localized to the basal side of the intestinal epithelium.
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Figure 2.5. Immunofluorescent staining for ZO-1 and Ezrin
(A-F) ZO-1 and (G-L) Ezrin at E12.5, E14.5, and P0.
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Figure 2.6. Immunofluorescent staining of Ki67
(A,B) E12.5 and (C,D) P0 intestines.
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Figure 2.7. Assessment of proliferation in Foxl1-Cre; Wnt5af/f mice
(A,B) Immunofluorescent staining for control and experimental mice at E12.5. (C) Rate of
proliferation in E12.5 intestines quantified by density (number of phosphorylated histone H3 (pHH3)
positive cells divided by area of epithelium). For each embryo, four different regions of the intestine
were imaged and quantified. (D,E) Immunofluorescent staining for control and mutant mice at P0.
(F) Rate of proliferation in P0 intestines quantified by number of pHH3 positive cells in the
epithelium per length of intestine. For each neonatal sample, 6-8 different regions of the intestine
were imaged and quantified. (ns) indicates no statistical significance.
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Figure 2.8. Quantification of apoptosis by TUNEL staining
(A,B) Immunofluorescent staining image for control and mutant mice at E12.5. (C) Rate of
apoptosis in E12.5 intestines quantified by density (number of TUNEL-positive cells divided by area
of epithelium). For each embryo, four different regions of the intestine were imaged and quantified.
(D,E) Immunofluorescent staining for control and mutant mice at P0. (F) Rate of apoptosis in P0
intestines quantified by number of pHH3 positive cells in the epithelium divided by length of
intestine. For each neonatal sample, 6-8 different regions of the intestine were imaged and
quantified. (*) indicates significant at p < 0.05, (ns) indicates no significance.
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CHAPTER 3. HIGHLY MULTIPLEXED IMAGE ANALYSIS OF INTESTINAL TISSUE
SECTIONS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

This chapter was adapted from Highly multiplexed image analysis of intestinal tissue sections in
patients with inflammatory bowel disease. Kondo A, Ma S, Lee MYY, Ortiz V, Traum D, Schug J,
Wilkins B, Terry NA, Lee H, and Kaestner KH. Gastroenterology (In Press).
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ABSTRACT
Significant progress has been made since the first report of inflammatory bowel disease
(IBD) in 1859, following decades of research that contributed to the understanding of the genetic
and environmental factors involved in IBD pathogenesis. Today, a range of treatments is available
for directed therapy, mostly targeting the overactive immune response. However, the mechanisms
by which the immune system contributes to disease pathogenesis and progression are not fully
understood. One challenge hindering IBD research is the heterogeneous nature of the disease and
the lack of understanding of how immune cells interact with one another in the gut mucosa.
Introduction of a technology that enables expansive characterization of the inflammatory
environment of human IBD tissues may address this gap in knowledge. We utilized the imaging
mass cytometry (IMC) platform to perform highly multiplex image analysis of IBD and healthy deidentified intestine sections (6 Crohn’s disease compared to 6 control ileum; 6 ulcerative colitis
compared to 6 control colon). The acquired images were assigned grades of inflammation severity
based on histological features of adjacent H&E tissue sections. We assigned over 300,000 cells to
unique cell types and performed analyses of tissue integrity, epithelial activity, and immune cell
composition with spatial resolution. The intestinal epithelia of IBD patients exhibited increased
proliferation rates and expression of HLA-DR compared to control tissues, and both features were
positively correlated with the severity of inflammation. The neighborhood analysis determined
enrichment of regulatory T cell interactions with CD68+ macrophage, CD4+ T cell, and plasma cell
in both forms of IBD, while activated Lysozyme C+ macrophages were preferred Treg neighbors in
Crohn’s Disease but not ulcerative colitis. Together, our study demonstrates the power of IMC and
its ability to both quantify immune cell types and characterize their spatial interactions within the
inflammatory environment by a single analysis platform.
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INTRODUCTION
Inflammatory bowel disease (IBD) is a chronic relapsing and remitting condition that affects
approximately 6.8 million people worldwide (Alatab et al., 2020; Windsor & Kaplan, 2019). Since
the first report of this disease in 1859 (Wilks, 1859), our understanding of both types of IBD, Crohn’s
disease (CD) and ulcerative colitis (UC), has improved dramatically. Thus, we now appreciate in
particular the contributions of genetic and environmental risk factors, dysbiosis, and the immune
response in disease pathogenesis. However, despite dramatic improvements in therapy, IBD
continues to lower the quality of life of affected patients and increases risk for colon cancer. Young
age and extensive bowel involvement are some of the features for high risk of progressive disease
(Duricova et al., 2017; Monstad et al., 2014), and both conditions cause significant morbidity with
not only complications from severe disease and extra-intestinal manifestations, but also higher
rates of anxiety, depression, and alienation (Regueiro et al., 2017).
Clinically, IBD is difficult to diagnose. CD has no pathognomonic features; thus, its
diagnosis relies on combination of clinical suspicion, based on findings on physical exams,
laboratory tests, radiology, endoscopy, and histology (Lichtenstein et al., 2018). CD can affect any
part of the gastrointestinal tract with about one third equal involvement in the colon, ileum, and
neoterminal ileum (Satsangi et al., 2006; Thia et al., 2010). UC, on the other hand, shows a distinct
continuous inflammation involving the distal rectum that can extend up to the ileum as backwash
ileitis in 35% of UC patients (Patil & Odze, 2017; Rubin et al., 2019). Hence, differentiation between
the two entities can become challenging when there is only colonic involvement. Furthermore, there
is currently a large unmet need for improved treatment of IBD patients who do not respond to
currently available therapeutics. Due to the heterogeneous nature and complexities of IBD, the
development and utilization of novel advanced technologies are needed to elucidate the impact of
individual immune cells and molecular pathways in the inflammatory pathogenesis of IBD.
Recently, there has been an immense expansion in the spatial-proteomics and transcriptomics (spatial-omics) technologies for applications in human disease research. One
technology, termed Imaging mass cytometry (IMC), is a highly multiplexed imaging platform that
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employs heavy metal-conjugated antibodies and relies on the quantification of UV-ablated tissue
particles by time-of-flight mass spectrometry, thereby retaining spatial information of antigen
abundance. This technology allows for visualization of over 30 antigens in a given tissue (Giesen
et al., 2014; Wang et al., 2019), which is superior to the 2-4 channels used in traditional
immunohistochemistry (IHC) and immunofluorescence (IF) techniques, and enables extensive
image analysis from a single tissue section.
Here, we utilized IMC on human IBD tissues to perform targeted spatial proteomics to
quantify epithelial integrity and immune cell composition in the inflamed mucosal environment. We
also performed image analysis based on histological inflammation severity, which we obtained from
H&E staining of adjacent tissue sections from each patient biopsy. Finally, we took advantage of
the spatial information retained by IMC and performed neighborhood analysis for elucidating the
cell-to-cell interactions of regulatory T cells with other immune cell types in CD and UC. We believe
this technology is a promising tool for application in a bedside-to-bench-to-bedside approach
(Pizarro et al., 2019) to define subpopulations of IBD based on clinical and histopathological
presentations, determine biomarkers of therapeutic efficacy, and identify novel therapeutics.

70

MATERIALS AND METHODS

Ethical Approval
Human tissue sections used in this study were procured from the Children’s Hospital of
Philadelphia and met the criteria for de-identified data. Our study is not considered human subjects
research in accordance to Section 164.514(a) of the HIPAA Privacy Rule.

Antibody conjugation and validation by immunofluorescence staining
Seven antibodies in the panel were conjugated using the Maxpar X8 Multimetal Labeling
Kit (Fluidigm) following the instructions manual (Table 3.1), and pre-conjugated and postconjugated antibodies were validated by indirect immunofluorescence staining (Figure 3.1). Briefly,
the sections were dewaxed (2 x 10’ Xylene, 2 x 10’ 100% ethanol (EtOH), 5’ 95% EtOH, 5’ 90%
EtOH, 5’ 80% EtOH, 5’ 70% EtOH; 10’ ddH2O) and subjected to antigen retrieval in a pressure
cooker (Biocare Medical) at 95°C for 30’ in Tris/EDTA buffer (10mM Tris, 1mM EDTA, pH 9.0). The
samples were incubated in 1X PBST for 20’, blocked with 3% BSA in 1X PBS for 1 hr, and incubated
overnight in an antibody cocktail (diluted in 0.5% BSA/1X PBS solution) at 4°C. An anti-E-cadherin
antibody was used to visualize the epithelium (RD Biosystems, 1:300). The next day, sections were
washed in 1X PBS, incubated with secondary antibodies for 2 hr at room temperature (RT), and
counterstained with Hoechst stain (Invitrogen, 1:10,000). The sections were mounted using
mounting solution and imaged using a Leica SP8 confocal microscope.

Imaging mass cytometry
Paraffin-embedded sections in the study were prepared using patient biopsy samples cut
to a thickness of 5µm. The sections were stained using the methods described above, with the
following changes: On the first day after blocking, sections were incubated overnight with a metalconjugated antibody cocktail (diluted in 0.5% BSA/1X PBS solution) at 4°C (Table 3.2). The next
day, sections were washed with 1X PBS for 5’, then incubated with Iridium solution (Intercalator-Ir,
71

Fluidigm, 1:400 in 1X PBS) at RT for 30’. The sections were washed with 1X PBS for 2 x 5’ and
quickly washed with ddH2O 3 times, then allowed to thoroughly air dry. Image acquisition was
performed using the Hyperion Tissue Imager (Fluidigm) connected to Helios mass cytometer
(Fluidigm), and CyTOF Software (Fluidigm, version 7.0.8) was used to tune the instrument as
described in the manufacturer’s instruction manual. The tissues were ablated at a laser frequency
of 200 Hz. Mcd (MathCad) files generated from the acquisition were converted to 16-bit multi tiff
files using the MCD Viewer software (Fluidigm, version 1.0.5).

Cell segmentation
A decision forest learning method was used to detect regions of tissue versus background
in each image using the Vis software (Visiopharm). From the tissue region, the nuclear channel (Ir193) was passed through a 3x3 pixel medium filter, followed by a polynomial local linear step to
identify round objects. The E-cadherin channel was used to identify epithelial nuclei. All segmented
nuclei were filtered for a maximum diameter of 8µm and expanded by up to 3 pixels to approximate
the cellular outline. Finally, all channels were passed through a 3x3 pixel median filter, and the
mean intensity of each channel was calculated for all cells (Figure 3.2).

Data filtering
Nine out of 57 images were considered unsuitable for downstream analysis and were
removed – including six that were primarily made up of Peyer’s patches, one image where the
signal intensities of all channels were much lower than those of the other images, and two that had
unfavorable sectioning. Due to this filtering step, one control ileum patient sample was removed
completely from further analysis (Table 3.3). Cells with abnormally high mean intensity signals due
to technical artifacts, or “edge effect” cells, were manually removed using FIJI and the EBImage
package in R (Pau et al., 2010). Finally, cells with raw histone mean intensity values above 750
were removed (Figure 3.3).

72

Cell annotation and analysis
Manual gating was performed for each channel of each image to determine the threshold
signal intensity value that distinguishes a positive signal from the background. After thresholding,
Boolean rules were used to assign each cell to a specific cell type (Table 3.4). Cell type annotation
was validated by pseudo flow plots for cell-type specific expression patterns, and by overlaying the
X and Y coordinates of cells onto IMC pseudo-color images (Figure 3.4, Figure 3.5). For immune
cell composition analyses, lymphoid tissues and submucosal tissues were masked and removed
using EBImage to prevent any skewing. R scripts for data visualization were adapted from a publicly
available CyTOF analysis pipeline (Nowicka et al., 2019).

Testing for cell differential expressions and proliferation rates
To test for differences in cell expressions and proliferation rate between conditions,
(generalized) linear mixed effect models (GLM) (Breslow & Clayton, 1993) were fitted on median
cell expressions and proportions of specific cell types, allowing for sample-specific random effects.
For example, the following GLM was fitted for per-image E-Cadherin median expressions for all CD
vs. control ileum (CI) images:
𝑌!" ∼ 𝛽# + 𝛽$% 𝐶𝐷!" + 𝑏!
where 𝑌!" is the median expression of E-Cadherin in sample 𝑖, image 𝑗. The fixed effect 𝛽$%
characterizes the overall E-Cadherin expression differences between CD and CI images. 𝑏! is a
sample-specific random effect accounting for within-sample correlations.
For per-image Ki67+ epithelial cell proportions for all CD/CI images, the following model
was fitted:
log

𝜋!"
∼ 𝛽# + 𝛽$% 𝐶𝐷!" + 𝑏!
1 − 𝜋!"

where 𝜋!" is the proportion of Ki67+ epithelial cells in sample 𝑖, image 𝑗. The fixed effect 𝛽$%
characterizes the overall log odds ratio between CD and CI images of Ki67+ epithelial cells. 𝑏! is
sample-specific random effect. Across condition pair tests (e.g. CD vs. CI), the p-values for
73

differences were corrected for multiple-comparison with the Benjamini-Hochberg procedure
(Benjamini & Hochberg, 1995).

Neighbor analysis
To test for the enrichment of interaction between cell pairs, GLM was adopted to address
within-sample and within-image cell-cell correlations, while accounting for the chance of cells in the
same image to randomly interact with each other19. First, cells within 15 pixels were labeled as
interacting with each other. For statistical modeling, using regulatory T cell (Treg)-CD4 T cell (CD4)
interaction as an example, the following model was fitted for all Tregs:

log

𝜋!"&
𝜋0!"
∼ log
+ 𝛽# + 𝛽$% 𝐶𝐷!"& + 𝛽'$ 𝑈𝐶!"& + 𝛽()*)+ 𝑐𝑜𝑙𝑜𝑛!"& + 𝑏! + 𝑐!" + 𝑒!"&
1 − 𝜋!"&
1 − 𝜋0!"

where, i indicates sample, j indicates image, and k indicates individual Tregs. 𝜋!"& is the proportion
of CD4 of all cells interacting with a given Treg 𝑖𝑗𝑘. 𝜋0!" as an offset is the overall proportion of CD4
in the i-th sample, j-th image; this is the expected proportion by random chance for a Treg to
interact with CD4. For the fixed effects, 𝛽# is the overall difference (log odds ratio) between
observed and expected CD4 interaction probabilities of Tregs across samples and images. Other
covariates can be interpreted correspondingly: for example, 𝛽$% is the overall log odds ratio of CD4
interactions between CD Tregs and control Tregs. 𝑏! denotes subject-specific, 𝑐!" image-specific,
and 𝑒!"& cell-specific random effects. Importantly, spatial correlation between cell pairs within the
same image were allowed. Specifically, 𝐶𝑜𝑟𝑟(𝑒!"& , 𝑒!"& ! ) = exp −𝜌𝑑&& ! , where 𝑑&&, is the distance
between the two cells and 𝜌 is a scaling parameter to be estimated during the model fit. Model
fitting was performed with the R package spaMM (Rousset & Ferdy, 2014) using the ML procedure.
Statistical inference on the fixed effects was performed with likelihood ratio tests (Table 3.5).
To test for Tregs’ interaction difference between activated vs. non-activated immune cells,
the above GLMM was modified to account for potential correlations between the active and nonactivated immune cell interactions. For example, for testing CD38+ CD8+ T cells (CD38+/CD8+)
compared to CD38- CD8+ T cells (CD38-/CD8+), the following model was fitted:
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log

𝜋!"&*
𝜋0!"*
∼ log
+ 𝛽# + 𝛽$%-." 𝐶𝐷38/
!"&* + 𝑏! + 𝑐!" + 𝑒!"& + 𝑓!"&*
1 − 𝜋!"&*
1 − 𝜋0!"*

𝜋!"&* is the proportion of CD8+ T cells for each Treg. i, j, and k are the same as the base neighbor
analyses. Additionally, 𝑙 ∈ {0, 1} indicates CD38 activation status for CD8+ T cells. That is, 𝜋!"&0 is
the proportion of CD38+/CD8+ neighbors for the Treg and 𝜋!"&# is the proportion of CD38-/CD8+.
𝜋0!"* is the offset term for overall proportion of CD38+ (𝜋0!"0 ) and CD38- (𝜋0!"# ) CD8+ T cells in the
image. The fixed effect 𝛽$%-." thus indicates the log odds ratio contrasting the proportion of
CD38+/CD8+ versus CD38-/CD8+ in Treg neighborhoods, while accounting for the expected
probability of interacting with these cell subsets by chance. 𝑏! and 𝑐!" still indicate sample- and
image-specific random effects. 𝑒!"& is cell-specific random effect that accounts for the correlation
of CD38+/CD8+ and CD38-/CD8+ proportions for the same Treg; 𝐶𝑜𝑟𝑟(𝑒!"& , 𝑒!"& ! ) = 0 for 𝑘 ≠ 𝑘 , as
the spatial correlation of different Tregs in the same image is accounted for by the term 𝑓!"&* . Lastly,
𝑓!"&* specifies the same spatial correlation as in the base neighbor analysis model.
𝐶𝑜𝑟𝑟(𝑓!"&* , 𝑓!"& !* ) = exp −𝜌𝑑&& ! where 𝑑&& ! is the distance between the two cells, while
𝐶𝑜𝑟𝑟K𝑓!"&* , 𝑓!"& !*! L = 0 for 𝑙 ≠ 𝑙, , as the correlation between CD38+/CD8+ and CD38-/CD8+ for both
Treg is already accounted for by 𝑒!"& . The above model was fitted for subsets of either CD or UC
samples to obtain disease-specific effects, again with spaMM (Rousset & Ferdy, 2014) (Table 3.6).
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RESULTS

Imaging mass cytometry captures and identifies major epithelial, stromal, and immune cell
populations in inflammatory bowel disease.
Our study included 24 formalin-fixed, paraffin-embedded human intestine sections which
were procured from the Children’s Hospital of Philadelphia. These sections were composed of ileitis
biopsies from six Crohn’s disease (CD) patients, colon biopsies from six ulcerative colitis (UC)
patients, as well as six healthy control ileum (CI) and six healthy control colon (CC) samples
(collectively referred to as “disease groups”) (Table 1, Table 3.7). Critically, all CI and CD biopsies
were taken from the terminal ileum. We did not analyze any colonic samples from CD patients, and
the CC and UC colon samples were collected from a different group of individuals.
We stained the tissue sections with a panel of 31 antibodies specific for structural,
epithelial, and immune cell types, including markers for epithelial cells (E-cadherin and PanKeratin), goblet cells (Mucin 2), Paneth cells (Lysozyme C), smooth muscle and myofibroblasts
(alpha smooth muscle actin (ASMA)), stromal cells (Vimentin), NCAM (CD56), nuclei (Histone H3),
and the extracellular matrix (Collagen Type I) (Table 3.2). The majority of the panel was used for
identifying immune cell types (CD45) such as T cells (CD3, CD4, CD8, Foxp3, CD45RO), B cells
(CD20), plasma cells (CD27, CD38), and myeloid cells (CD11b, CD68, CD14, CD16, Human
Leukocyte Antigen – DR isotype (HLA-DR)). Finally, we included markers for assessment of cell
function and activity, such as cytotoxicity (Granzyme B), antimicrobial activity (Lysozyme C),
lymphocyte activation (CD69), and proliferation (Ki67).
A total of 57 multiplex images from the 24 stained sections were acquired using IMC, which
were then processed for cell segmentation using the Vis software (Visiopharm) (Figure 3.2). Image
acquisition and cell segmentation yielded a total of 521,783 captured cells, each with a unique
protein expression profile and X & Y coordinates indicating cell location within an image (Table
3.3). After filtering out cells that had high, nonspecific autofluorescence signals and removing low
quality images (Figure 3.3), 396,890 cells from 48 images were retained (51,335 from CI, 163,438
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from CD, 60,015 from CC, 122,114 from UC). We defined marker expression parameters to assign
cell types using a Boolean method (Table 3.4, Figure 3.6). Ultimately, the 13 cell types identified
constituted 3 broad groups: epithelial cells (E-cadherin+), stromal cells (Vimentin+), and immune
cells (CD45+) (Figure 3.6A-C). Within the immune cell group, we identified T helper cells, cytotoxic
T cells, regulatory T cells (Tregs), B cells, plasma cells, resident tissue macrophages, and
monocytes. CD16+ and CD11b+ myeloid cells could not be classified into more distinct immune cell
groups due to the limitation of our antibody panel, but are most likely comprised of dendritic cells,
neutrophils, eosinophils, and mast cells (Figure 3.6D, Figure 3.7). Within each disease group, we
achieved similar cell composition distributions across the samples, to enable us to perform
downstream analyses with comparable tissue structures (Figure 3.6E). Thus, we show that our 31antibody panel can identify major intestinal and immune cell types for performing multiplexed
analysis of human IBD tissue sections, which we demonstrate in the following sections.

Histological assessment reveals variable active and chronic inflammation severity in IBD
tissues.
Because IBD is a heterogeneous group of diseases where clinical and histopathological
presentations vary across patients (especially in CD), we assigned inflammation grades to the 48
images by assessing the histopathological features of adjacent H&E-stained sections (Table 1). A
status of active inflammation was assigned if an image had neutrophil infiltration. In UC specifically,
we identified samples where epithelial infiltration by immune cells (cryptitis) caused the formation
of crypt abscesses (Geboes, 2003) (Figure 3.8A,B). A status of chronic inflammation was assigned
based on presence of crypt distortion and pyloric metaplasia (Cuvelier et al., 1987) (Figure 3.8C,D).
Based on these features, the following inflammation grades were assigned to each image: (1)
control (all control ileum and control colon images), (2) uninflamed, (3) mildly chronic, (4) chronic,
(5) active, (6) chronic and active, and (7) severely chronic and active (Table 3.3). We emphasize
that the H&E sections used for inflammation grading were of the same regions as those analyzed
by IMC. In addition, because our study uses de-identified data without knowledge of clinical
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phenotype of the patients, all results in our study are biopsy-site specific results correlating
histologically assigned pathology to changes in density and distribution of various cell type and
protein expression levels.
Two images were classified to have severely chronic and active inflammation, both of
which came from a 19-year old male with UC. When we visualized the tissue structure of our IBD
samples using pseudo-color overlay images of the ASMA, Collagen Type I and CD56 channels,
one image from this patient showed presence of fibrosis, as evidenced by high collagen deposition
in the gut mucosa and thickening of ASMA+ muscularis mucosa (Figure 3.9). Fibrogenesis is a
natural healing process associated with increased number of myofibroblasts, increased collagen
deposition, angiogenesis, and mesenchymal cell hyperplasia (Lenti & Di Sabatino, 2019). While it
is a complication more commonly observed in CD that can lead to the formation of strictures (Lenti
& Di Sabatino, 2019; Louis et al., 2001; Rieder et al., 2017), a recent study found that presence of
fibrosis is positively correlated with severity of chronic inflammation in UC (I. O. Gordon et al.,
2018). This supports our identification of fibrosis in the UC patient with severely chronic and active
inflammation.

Proliferation rate and HLA-DR expression in intestinal epithelial cells are increased in IBD
and are correlated with severity of inflammation.
Intestinal tissues in IBD are marked by ulcerations and mucosal erosions, which lead to
damage of intestinal epithelial cells. As epithelial cells activate wound repair mechanisms,
increased proliferation is frequently observed (Franklin et al., 1985; MACDONALD, 1992). We
compared the proliferative activity in CD samples to those of CI sections, and UC to CC by
quantifying the proportion of Ki67+ epithelial cells in each image (Figure 3.10A-E; Figure 3.11). As
expected, we observed an increase in epithelial cell proliferation in both CD and UC compared to
their respective controls. We also investigated whether epithelial expression of E-cadherin and
HLA-DR are altered. E-cadherin is a cell adhesion molecule required for maintaining epithelial
structural integrity, and therefore the decrease in epithelial barrier function is one of the triggers of
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IBD pathogenesis (Karayiannakis et al., 1998; Kucharzik et al., 2001). In fact, genome-wide
association studies (GWAS) have identified several genes important for epithelial structural
integrity to be risk loci for IBD (Anderson et al., 2011; Franke et al., 2010). HLA-DR is an MHC II
protein that is normally only expressed on the surface of antigen-presenting immune cells that can
be elevated in IBD epithelial cells, although the exact role of HLA-DR+ epithelial cells is unknown
(Biton et al., 2018; Ouyang et al., 1988; Selby et al., 1983). While we did not observe differences
E-cadherin expression in both CD and UC groups compared to their respective control groups,
HLA-DR was significantly increased in CD and UC epithelial cells (Figure 3.10F-J; Figure 3.11).
We also investigated whether epithelial proliferation rate, E-cadherin expression, and HLADR expression correlated with severity of inflammation by visualizing the data shown in Figure 2
by inflammation grade of each image (Figure 3.12). While in the UC colon we observed similar
rates of proliferation between uninflamed UC and inflamed UC, in the CD ileum we observed an
increasing trend in proliferation associated with intensity of inflammation (Figure 3.12A).
Furthermore, we found that HLA-DR expression correlates with severity of inflammation in both
ileum and colon, providing further support for a role of HLA-DR+ epithelial cells in the inflammatory
mucosal environment of IBD (Figure 3.12B). Notably, when we compared images from the same
patient with varying degrees of inflammation (Figure 3.12, data points from the same patient
connected by a line), we also observed a positive correlation between inflammation and epithelial
proliferation/HLA-DR expression within the same patient samples. These differential rates of
proliferation and levels of expression of HLA-DR within the same patient biopsy emphasize the
value of maintaining spatial resolution when studying IBD. This is especially true in the case with
CD, where inflammation occurs in patches along the gastrointestinal tract (called skip lesions).
Therefore, IMC meets the need for future IBD research to consider variabilities in tissue
microenvironment when studying disease mechanisms and identifying novel therapeutics.

IBD tissues exhibit unique immune cell profiles based on disease type and inflammation.
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Immune cells play a major role in the pathogenesis of IBD, where overactivation of the
innate and adaptive immune responses leads to injury of mucosal tissue (Sartor, 2006). Therefore,
we next set out to perform cell composition analysis of immune cells to characterize the cellular
profiles of CD and UC. In the cell type annotation process described above, we identified major
immune cell populations including CD4+ T helper cells, CD8+ cytotoxic T cells, Foxp3+ Tregs, CD20/CD27+/CD38+ plasma cells, CD68+ resident macrophages, and CD14+ monocytes (Figure 3.6).
CD20+ B cells were also identified but were excluded from further analysis because of their
predominance in lymphoid follicles and scarcity in the lamina propria (Spencer & Sollid, 2016). We
also excluded the broader immune cell groups annotated as CD16+ myeloid cells and CD11b+
myeloid cells from all downstream analyses.
For each immune cell type, we quantified abundance as a proportion of the total number
of the cell type of interest out of the total number of cells in the image (Figure 3.13A). CD4+ T cells
were significantly increased in CD but not in UC, and CD8+ T cell abundance varied across the
disease groups. Macrophages of the intestinal lamina propria (CD68+ macrophages) are the
resident macrophages during normal intestinal homeostasis (GRIMM et al., 1995), which were less
abundant in the normal ileum compared to the control colon, while they were increased in the CD
ileum compared to control.
Proinflammatory signals in IBD tissue promote infiltration of peripheral monocytes (CD14+
monocytes) into the inflamed area, and therefore the presence of CD14+ monocytes in the lamina
propria is a sign of active inflammation (GRIMM et al., 1995; Kamada et al., 2008; Platt et al., 2010;
Rieder et al., 2017). Additionally, plasma cells are an active form of B cells, which migrate from
the lymph follicles to the lamina propria during inflammation to secrete IgA to protect the intestinal
mucosa from invading pathogens, and are increased in frequency in IBD tissues (J. N. Gordon et
al., 2008; Spencer & Sollid, 2016). Quantification of these inflammatory immune cell populations
by IMC showed that they are increased in both CD and UC, as expected (Figure 3.13A). Finally,
Tregs are essential for suppression of the immune response to prevent an overaggressive
response and consequently are increased in abundance in inflamed tissues (Maul et al., 2005;
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Vignali et al., 2008), which we observed in both CD and UC (Figure 3.13A). In general, CD14+
monocytes, plasma cells, and Tregs were increased with severity of inflammation in both CD and
UC (Figure 3.14).
The IMC technology allows for quantification of multiple cell types in a large set of samples
at once. We applied this capability to perform hierarchical clustering of all images based on their
immune cell composition profiles for comparisons between disease groups and inflammatory
states. From the heatmap displayed in Figure 3.13B, we can conclude the following: (1) the
clustering mostly grouped control images separately from disease images as expected; (2) chronic
inflammation in CD is marked by increased CD4+ T cell and Treg frequencies; and (3) images of
chronic and active inflammation in UC are marked by increased frequency of plasma cells and
CD14+ monocytes. Finally, (4) four CD images of chronic inflammation and two UC images of
chronic & active inflammation show increased presence of Tregs, plasma cells, and CD14+
monocytes (Figure 3.13B). Thus, analysis of the data by hierarchical clustering allows us to quickly
assess similarity in immune composition profile between the patients and even between different
tissue regions from the same patient.

Tissue-resident macrophages and CD8+ T cells exhibit increased inflammatory activity in
the lamina propria of IBD patients.
Our cell composition analysis showed no differences in mucosal CD8+ T cell abundance
across disease groups, and the increase in CD68+ macrophage density was only observed in CD
(Figure 3.13A). Therefore, we next set out to determine whether immune cell composition could
be better visualized by profiling subsets of CD8+ T cells and CD68+ macrophages based on
expression of markers of cell state and activity (Figure 3.15). Specifically, CD38 expression in T
lymphocytes has been shown to be increased in the inflamed mucosa (Funderburg et al., 2013;
Joosse et al., 2019); CD69 is a marker of transient lymphocyte activation (Moretta et al., 1991);
and Granzyme B is a cytotoxic protein expressed in CD8+ T cells and other immune cells in order
to destroy infected host cells (Boivin et al., 2009). Quantification of CD38+, CD69+, and Granzyme
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B+ CD8+ T cells showed an increase in CD38+ and Granzyme B+ CD8+ T cells in both CD and UC,
but no changes in CD69+ CD8+ T cell frequencies (Figure 3.15A, B). Next, we quantified the
proportions of Lysozyme C+ and Granzyme B+ macrophages (Figure 3.15A,C). Lysozyme C is an
antimicrobial protein that is commonly known to be secreted by Paneth cells in the small intestine
to protect the mucosal layer from invasion by foreign pathogens, but is also produced by
macrophages in an inflamed environment to destroy pathogens once they are taken up by the cells
in phagosomes (Callewaert & Michiels, 2010; Ragland & Criss, 2017). We found an increase in
abundance of Lysozyme C+ CD68+ macrophages in both CD and UC, and an increase in
abundance of Granzyme B+ CD68+ macrophages in UC but not CD (Figure 3.15A,C-E; Figure
3.11). Therefore, even though both CD8+ T cell and CD68+ macrophage compositions were
variable across the four disease groups (Figure 3.13), we show that both cell types have increased
expression of markers indicative of increased inflammatory and antimicrobial activity in IBD.

Neighborhood analysis reveals selective interactions of regulatory T cells with immune cell
populations.
We saw earlier that the abundance of Foxp3+ Tregs is increased in both IBD groups
compared to healthy controls (Figure 3.13B). Tregs play a critical role in immunosuppression in
the inflamed intestinal mucosa (Wan & Flavell, 2008). There are two types of Tregs – naturally
occurring Tregs that develop in the thymus, and acquired Tregs which derive from conventional T
cells induced to become immunosuppressive (Wan & Flavell, 2008). Currently, Foxp3 is the most
commonly used marker for naturally occurring Tregs (Fontenot et al., 2005). Tregs use both
contact-dependent and contact-independent mechanisms to suppress neighboring immune cells.
For example, Tregs secrete anti-inflammatory cytokines to inhibit effector T cell activity and bind to
antigen presenting cells to inhibit lymphocyte recruitment (Clough et al., 2020). Taking advantage
of the spatial information retained by IMC, we wanted to determine whether interactions of Tregs
with certain immune cell types occurred more frequently than expected in each disease group. To
this end, we performed neighborhood analysis to quantify enrichment of different immune cell types
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among Foxp3+ Treg neighbors (Table 3.5). Statistical testing for control ileum and control colon
groups was omitted from this part of the study due to insufficient number of Tregs in these groups.
In both CD and UC, Tregs were significantly enriched for CD68+ macrophage, CD4+ T cell, and
plasma cell neighbors compared to the random distribution, and Tregs were significantly enriched
for CD14+ monocyte and CD8+ T cell neighbors in CD but not UC (Figure 3.16A,C).
Finally, we set out to determine whether Tregs are more likely to interact with activated
rather than non-activated immune cell subsets. We performed neighborhood analysis centered on
Tregs’ interactions with CD38+ CD8+ T cells compared to CD38- CD8+ T cells, and Lysozyme C+
CD68+ macrophages compared to Lysozyme C- CD68+ macrophages in CD and UC. We chose
these cell type subsets based on above-mentioned results where CD38+ CD8+ T cells and
Lysozyme C+ CD68+ macrophages were increased in abundance in both CD compared to CI and
UC compared to CC (Figure 3.15), and because abundance of both subsets showed a positive
correlation with severity of inflammation (Figure 3.17). We performed interaction testing after
adjusting for the natural difference in frequency of marker-positive vs. marker-negative cells, and
found that in CD, Tregs interact significantly more with Lysozyme C+ CD68+ macrophages than
Lysozyme C- CD68+ macrophages, while this does not hold true in UC. In both groups, there was
no enrichment of CD38+ CD8+ T cells over CD38- CD8+ T cells as Treg neighbors (Figure 3.16B,C,
Table 3.6).
Interestingly, it is believed that Tregs contribute to IBD pathology by insufficient
suppression of active immune cells. This is supported by the evidence that although Treg density
is increased in the inflamed IBD mucosa, the recruitment of Tregs from the blood to the inflamed
site is significantly lower in IBD inflammation than in non-IBD inflammation (Maul et al., 2005). One
might assume that Treg neighbors are enriched for more immune cells in CD because there is a
higher abundance of Tregs in CD than UC (Figure 3.13A), but we note that our neighborhood
analysis methodology corrects for abundance of Tregs and neighboring immune cells for each
image. Therefore, we speculate that the lower enrichment of neighboring immune cells around
Tregs in UC than CD may be due to functional defects, i.e. an inability to detect inflammatory
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signals. This would also suggest that Tregs in the UC group are less sensitive in detecting
Lysozyme C+ CD68+ macrophages than in CD. A deeper analysis of Treg interactions in a larger
cohort study is crucial for a better understanding of the differential cell-to-cell interaction patterns
between CD and UC, and the neighborhood analysis methodology would be strengthened further
by inclusion of both inflamed and uninflamed tissues for each patient to account for patient-specific
variability.
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DISCUSSION
Inflammatory bowel disease (IBD) is a complex disease with a broad heterogeneity of
clinical symptoms and severity, disease onset, and triggers of pathogenesis. While significant
efforts have been made in the development of therapeutics to treat CD and UC, there is a large
unmet need for improving drug efficacy, as degree and duration of remission are highly variable
among IBD patients (Paramsothy et al., 2018). Utilization of more advanced technologies is
essential for addressing these unmet needs.
Here, we employed a highly multiplex imaging platform called IMC to detail histological
features and cellular profiles of six Crohn’s disease and six ulcerative colitis patients using a panel
of 31 antibodies marking epithelial, stromal, and immune cell populations stained for and analyzed
simultaneously. We aimed to demonstrate the power of IMC by performing highly multiplexed
image analysis to characterize the IBD inflammatory environment – including epithelial proliferation,
E-cadherin expression, and HLA-DR expression, immune cell composition, and cell-to-cell
interactions of Tregs. While it is true that several of our individual findings have been reported, the
recapitulation of previous findings is in fact an essential step in the development and incorporation
of a novel technology for much larger future IBD studies. Beyond these proof-of-concept
assessments, we also performed novel analyses of cell-to-cell interactions of Tregs with other
immune cell types in the human intestinal mucosa, which are an important stepping-stone for future
IBD studies utilizing spatially resolved omics platforms.
The ability to perform numerous histological assessments from just one section per patient
makes IMC a more advantageous tool over traditional IHC and IF methodologies that are limited to
the simultaneous use of 3-4 markers due to overlapping fluorophore spectra. Staining sections with
30+ protein markers at the same time not only reduces the amount of biopsy tissue needed to stain
for multiple markers, but it also greatly expands the ways in which image analysis can be
performed. For example, one could utilize IMC to perform tissue-compartmentalized assessments
of immune cell types (i.e. epithelium vs. stroma, tumor vs. non-tumor) for identification of spatiallyresolved biomarkers in human disease. Furthermore, our Treg neighborhood analysis – which
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required markers for cell segmentation, tissue compartmentalization, and cell identification of six
immune cell types all in the same tissue sections – is impossible by IHC and IF. When considering
these factors, the superiority of highly multiplexed spatial technologies such as IMC over prior
technologies is apparent.
For reasons described above, the application of multiplexed imaging and spatial-omics
platforms such as IMC in human disease research is on the rise. However, as these technologies
are only just emerging, there is currently a lack of standard methods for image processing and
quantitative analysis. As a result, methods for processes such as cell segmentation differ across
previous studies, although more recently there has been some convergence towards the use of
machine learning approaches to improve segmentation accuracy. In our images, the highly variable
cell sizes and shapes found in the intestine made it difficult to accurately predict cell surfaces by
pixel classification machine learning only. We achieved optimal cell segmentation results by first
identifying the nuclear circumference, then expanding this circumference to a maximum of 8 ms
in diameter to approximate the extent of each cell. This segmentation approach was able to detect
cell surface signals for accurate cell type annotation. Despite the confidence in our analysis
methods, we believe the future of spatial analysis technologies relies on establishing standard
image processing and quantification pipelines to ensure reproducibility and allow comparisons
between independent studies.
IMC has high potential for advancing the IBD field in aspects of both discovery research
and clinical research. IBD continues to be a significant health burden around the globe (Alatab et
al., 2020) and there are unmet needs for patients who do not respond to available therapies.
Addressing these needs requires deeper understanding of the pathogenesis of IBD using large
human cohort studies based on histological and clinical presentations. Specifically, extensive
characterizations of IBD patients to identify subpopulations of disease is crucial for unraveling
mechanisms of this complex disease.
The two most common classes of currently available therapeutics, anti-TNF and anti-Integrin
agents, ameliorate the pathological consequences elicited by the inflammatory immune response.
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anti-TNF agents act to inhibit the inflammatory activity of myeloid cells, mainly monocytes and
macrophages, while anti-integrin agents act via suppression of T cell recruitment to the site of
inflammation (Paramsothy et al., 2018). Additionally, anti-IL12/23 biologic agents inhibit
inflammatory cytokine signaling. While their effectiveness is high, a subset of patients do not
respond to any of these, prompting participation in clinical trials where treatment failure is
unfortunately also observed (Paramsothy et al., 2018). Because of this and the fact that patients
with IBD show unique clinical presentations triggered by individual environmental and genetic
factors, development of novel and/or more targeted therapies based on disease stratification and
personal characteristics might prove to be more effective in managing disease.
We believe that IMC can be an even more powerful tool when combined with other genomic
platforms for a multi-omics approach to study IBD. The most widely used omics technology for IBD
has been RNA-sequencing, which does not retain spatial information and therefore cannot
determine the extent to which the results are contributed by gut-associated lymphoid tissues or
uninflamed tissue regions. While IMC provides the spatial information necessary to distinguish
between inflamed and uninflamed regions, there are certain limitations to consider when using this
technology alone; for example, our antibody panel is limited to 31 markers and the platform cannot
detect lowly expressed antigens. Therefore, a multi-omics approach can identify novel disease
pathways based on converging targets from transcriptomic and proteomic assays, while IMC can
provide essential information on cell-type-specific and cell-to-cell interaction-specific functions of
these novel pathways.
Finally, our study utilized 24 de-identified human IBD samples, and the pathological
information used in our analyses were based on the histopathological grading of adjacent H&E
sections rather than clinical presentations of the IBD patients. Future studies would greatly benefit
from using a larger cohort correlated to clinical information and analyzing several biopsies from
different segments of the bowel for each patient. This would help determine patient-specific
variabilities in cellular composition and activity, thus improving the robustness of analysis.
Furthermore, future deep histological characterization of multiple biopsies by IMC will be essential
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for clinical applications in determining importance of biopsy location, size, and number needed to
diagnose IBD, as well as for differentiating among different IBD subtypes and predicting therapeutic
choices. Thus, the incorporation of IMC technology as a more comprehensive histological
assessment tool for identifying biomarkers for novel therapeutic targets could prove useful in an
era striving for personalized medicine.
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TABLES

Antibody

Clone

Vendor

Dilution

HLA-ABC

EMR8-5

BD Biosciences

1:100

Mucin 2

Ccp58

Santa Cruz

1:200

CD56

Rabbit polyAb

Proteintech

1:00

Lysozyme C

E5

Santa Cruz

1:100

CD69

sc-373798

Santa Cruz

1:100

HLA-DR

TAL 1B5

Abcam

1:200

CD38

H-11

Santa Cruz

1:200

Table 3.1. Clone and dilution information for pre-conjugated antibodies
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Mass

Metal

Marker

Clone

Vendor

Dilution

141

Pr

ASMA

1A4

Fluidigm

1:600

143

Nd

Vimentin

RV202

Fluidigm

1:300

144

Nd

CD14

EPR3653

Fluidigm

1:200

145

Nd

HLA-ABC

EMR8-5

BD Biosciences

1:200

146

Nd

CD16

EPR16784

Fluidigm

1:200

147

Sm

Mucin 2

Ccp58

Santa Cruz

1:300

148

Nd

Pan-Keratin

C11

Fluidigm

1:300

149

Sm

CD11b

EPR1344

Fluidigm

1:200

151

Eu

CD107a

H4A3

Fluidigm

1:200

152

Sm

CD45

2B11

Fluidigm

1:200

153

Eu

CD56

Rabbit Poly Ab

Proteintech

1:300

154

Sm

B-actin

2F1-1

Fluidigm

1:300

155

Gd

Foxp3

236A/E7

Fludigim

1:75

156

Gd

CD4

EPR6855

Fluidigm

1:100

158

Gd

E-Cadherin

24E10

Fluidigm

1:300

159

Tb

CD68

KP1

Fluidigm

1:600

160

Gd

Lysozyme C

E5

Santa Cruz

1:200

161

Dy

CD20

H1

Fluidigm

1:300

162

Dy

CD8

C8/144B

Fluidigm

1:300

163

Dy

CXCR3

G025H7

Fluidigm

1:300

165

Ho

CD69

sc-373798

Santa Cruz

1:300

167

ER

Granzyme B

EPR20129-217

Fluidigm

1:200

168

Er

B56

Fluidigm

1:600

169

Tm

Ki67
Collagen
Type I

Polyclonal

Fluidigm

1:600

170

ER

CD3

Fluidigm

1:200

171

Yb

CD27

Polyclonal (C
terminal)
EPR8569

Fluidigm

1:100

172

Yb

CD57

HCD57

Fluidigm

1:200

173

Yb

CD45RO

UCHL1

Fluidigm

1:300

174

Yb

HLA-DR

TAL 1B5

Abcam

1:600

175

Lu

CD38

H-11

sc-373798

1:100

176

Ho

Histone H3

D1H2

Fluidigm

1:600

191/193

Ir

DNA

NA

Fluidigm

1:400

Table 3.2. Antibody panel used for acquiring images with IMC
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Condition

Sample
ID

CI_01

CI_02

Control
ileum
(terminal
ileum)

CI_03

CI_04

CI_05

CI_06

CD_07

CD_08

Crohn’s
disease
(terminal
ileum)

CD_09

CD_10

CD_11

CD_12

Control
colon
(colon)

CC_13

CC_14

Total
cells per
patient*

Total cells
per
disease
group*

Assigned
Inflammation
grade**

Image
name

Image size

Cells per
image*

CI_01.1

1000x1000

0

CI_01.2

1500x2000

0

CI_01.3

1750x2000

0

CI_02.1

1500x700

3,737

CI_02.2

2000x1000

13,763

CI_03.1

2000x1000

4,041

CI_03.2

2000x1000

4,660

CI_04.1

1500x1250

5,934

CI_04.2

1100x1000

4,198

CI_05.1

1500x500

0

CI_05.2

1300x1200

0

CI_05.3

1500x500

2,477

CI_06.1

2000x1800

9,787

CI_06.2

2000x1000

2,757

CD_07.1

1500x1500

9,287

CD_07.2

2100x1200

10,312

CD_08.1

2000x1500

24,657

CD_08.2

1100x1600

10,915

CD_08.3

2000x1500

9,919

mild chronic

CD_09.1

1500x1350

11,180

chronic

CD_09.2

1500x1100

7,929

CD_09.3

1000x1000

8,038

CD_09.4

1500x1500

0

CD_10.1

1500x1500

14,541

CD_10.2

2000x1500

5,176

CD_11.1

1750x800

6,556

CD_11.2

1000x750

0

CD_12.1

2000x2000

21,923

CD_12.2

1500x1500

12,131

CD_12.3

1500x1250

10,604

chronic

CC_13.1

1000x800

0

NA

CC_13.2

2000x800

9,085

CC_13.3

1000x800

3,592

CC_13.4

1000x800

4,596

CC_14.1

2000x600

5,340
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NA
0

NA
NA
control

17,500

control
control

8,701
51,354
10,132

control
control
control
NA

2,477

NA
control
control

12,544

control
active

19,599

uninflamed
chronic

45,491

chronic

chronic

27,147
163,168

chronic
NA
chronic

19,717

uninflamed
active

6,556

NA
chronic
chronic

44,658

17,273

control
60,016

control
control

13,571

control

CC_14.2

2000x750

8,231

CC_15

CC_15.1

700x1450

4,650

4,650

control

CC_16

CC_16.1

1450x1450

5,301

5,301

control

CC_17.1

1000x750

5,232

CC_17.2

1000x750

3,535

CC_18.1

1200x1200

6,694

CC_18.2

1500x1000

3,760

UC_19.1

1100x1000

5,349

UC_19.2

1100x1000

4,249

UC_19.3

1100x1000

0

NA

UC_20.1

700x1000

5,485

active

UC_20.2

700x1000

4,885

UC_20.3

1500x2000

12,692

UC_21.1

1000x2000

7,790

UC_21.2

1000x2000

5,793

CC_17

CC_18

UC_19

UC_20

Ulcerative
colitis
(colon)

UC_21

UC_22.1

2000x1500

22,740

UC_22.2

1500x1500

9,925

UC_23.1

1000x2000

8,252

UC_23.2

1000x2000

9,421

UC_24.1

2000x1000

8,084

UC_24.2

2000x1000

9,302

UC_24.3

1000x1000

8,385

UC_22

UC_23

UC_24

control

control

8,767

control
control

10,454

control
uninflamed

9,598

uninflamed

23,062

active
active
mild chronic

13,583
122,352
32,665

17,673

uninflamed
severe chronic &
active
severe chronic &
active
chronic & active
active
chronic & active

25,771

chronic & active
chronic & active

Table 3.3. Images acquired by Imaging Mass Cytometry
* Cell count after filtering step.
** NA indicates images that were not assigned grades of inflammation because they were not
included in the analysis.
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Broad cell types

Specific cell type

Markers

Epithelial cells

-

E-cadherin+/Pan Keratin+

Paneth cells

Lysozyme C

Goblet cells

Mucin 2

-

Vimentin+

NCAM

CD56+

ASMA+ cells

ASMA+

-

CD45+

CD8+ T cells

CD3+/CD8+

CD4+ T cells

CD3+/CD4+

Regulatory T cells

Foxp3+/CD3+/CD4 or Foxp3+/CD3+/CD8+

CD20+ B cells

CD20+

Plasma cells

CD27+/CD38+/CD20-

CD68+ Macrophages

CD68+

CD14+ Monocytes

CD14+/CD68-

Stroma

Immune cells

Table 3.4. Cell type annotation rules
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Neighbor cell

Disease

coefficient

variation

standard
deviation

P value*

Q value**

CD14+ monocyte

CD

-0.198

0.015

0.122

0

0

CD14+ monocyte

UC

-0.022

0.024

0.154

0.903

0.946

CD14 monocyte

CD_vs_UC

-0.176

0.039

0.197

0.342

0.665

CD4+ T cell

CD

0.508

0.004

0.066

1.22E-06

8.55E-06

CD4+ T cell

UC

0.455

0.009

0.095

2.90E-05

1.45E-04

CD4+ T cell

CD_vs_UC

0.053

0.013

0.116

0.651

0.866

CD

0.056

0.020

0.142

0

0

UC

-0.600

0.047

0.217

0.005

0.021

CD_vs_UC

0.656

0.067

0.259

0.012

0.043

CD8+ T cell

CD

0.043

0.008

0.092

0

0

CD8+ T cell

UC

0.011

0.017

0.130

0.935

0.946

CD8+ T cell

CD_vs_UC

0.032

0.025

0.159

0.838

0.946

plasma cell

CD

-1.037

0.028

0.167

2.75E-09

2.41E-08

plasma cell

UC

-0.854

0.036

0.190

1.33E-05

7.74E-05

plasma cell

CD_vs_UC

0.183

0.064

0.253

0.454

0.689

+

+

CD68
macrophage
CD68+
macrophage
CD68+
macrophage

Table 3.5. Neighborhood analysis interaction testing results centered on Treg neighbors
* P value based on whether Treg neighbors are enriched for a certain cell type more than expected
by chance.
** Benjamini-Hochberg adjusted Q values.
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Neighbor cell

Marker

Disease

coefficient

variation

standard
deviation

P
value*

Q
value**

CD68+
macrophage

Lysozyme C

CD

0.532

0.017

0.129

2.05E04

1.23E-03

CD8+ T cell

CD38

CD

-0.479

0.058

0.240

0.047

0.118

CD68
macrophage

Lysozyme C

UC

0.301

0.035

0.186

0.157

0.2376

CD8+ T cell

CD38

UC

0.423

0.046

0.215

0.059

0.118

+

Table 3.6 Neighborhood analysis interaction testing results for subset macrophages and
CD8+ T cells
* P value based on whether Treg neighbors are enriched for a certain cell type more than expected
by chance.
** Benjamini-Hochberg adjusted Q values.
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Group

Total
samples

Median
age (IQR)
in years

Female
(%)

Male
(%)

Neutrophil
infiltration
(%)

Cryptiti
s (%)

Chronic
inflammation
(%)

Granulomas (%)

Control
ileum

5

11
(5.5-16)

20

80

0

0

0

0

Crohn’s
disease

6

9
(7.75-16)

66.7

33.3

50

33.3

33.3

33.3

Control
colon

6

66.7

33.3

0

0

0

0

Ulcerativ
e colitis

6

50

50

83.3

83.3

50

0

16
(12.7517.25)
16.5
(14.2517.5)

Table 3.7. Patient sample information
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Group

Control
Ileum

Crohn’s
Disease

Control
Colon

Ulcerative
Colitis

Case ID

Age

Sex

Disease duration (yrs.)

RES19-37-01

16 years

Male

NA

RES19-37-02

11 years

Male

NA

RES19-37-03

16 years

Female

NA

RES19-37-04

5 years

Male

NA

RES19-37-05

6 years

Male

NA

RES19-37-06

16 years

Male

NA

RES19-37-07

8 years

Male

Diagnosed based on this biopsy

RES19-37-08

9 years

Female

Diagnosed based on this biopsy

RES19-37-09

16 years

Male

Diagnosed based on this biopsy

RES19-37-10

16 years

Female

7 years

RES19-37-11

7 years

Female

Diagnosed based on this biopsy

RES19-37-12

9 years

Female

Diagnosed based on this biopsy

RES19-37-13

18 years

Female

NA

RES19-37-14

16 years

Male

NA

RES19-37-15

9 years

Female

NA

RES19-37-16

16 years

Female

NA

RES19-37-17

14 years

Male

NA

RES19-37-18

17 years

Female

NA

RES19-37-19

16 years

Female

Diagnosed based on this biopsy

RES19-37-20

17 years

Male

1 year

RES19-37-21

16 years

Male

Diagnosed based on this biopsy

RES19-37-22

19 years

Male

Diagnosed based on this biopsy

RES19-37-23

9 years

Female

2 years

RES19-37-24

17 years

Female

Diagnosed based on this biopsy

Table 3.8. De-identified patient sample information used in the study
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FIGURES

98

99

Figure 3.1. Validation of homemade metal-conjugated antibodies
100

Pseudocolor overlay images of (A) HLA-ABC, (B) Lysozyme C, (C) Mucin 2, (D) CD56 (E), (E)
CD69, and (F) CD38. For each antigen, we first performed immunofluorescent staining (IF) on the
unconjugated antibodies, after which we conjugated the antibodies with lanthanide earth metals.
After conjugation, the antibodies were tested again by IF and finally validated by IMC. HLA-DR was
validated by our group in a previous study12. E-cadherin staining in green, and nuclear staining
(DAPI for IF; Iridium 191 for IMC) in blue, and antibodies of interest in red.
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Figure 3.2. Cell segmentation using Vis software
(A,G) Representative images of the nuclear (Iridium 193) and epithelial (E-cadherin) channels
acquired by IMC. (C,I) For each ROI, we first trained the software using a decision forest algorithm
102

to differentiate tissue region (highlighted in gray) to background. (E,K) The iridium and E-cadherin
channels were used to train the software to identify nuclei, and cell segmentation was determined
by expanding the nuclear masks by 3 pixels. The white box in panel A represents the zoomed in
images shown in B, D, and F, and the white box in panel G represents the zoomed in images shown
in H, J, and L.
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Figure 3.3. Removal of edge effects and high intensity signals
Representative IMC image of a tissue region with edge effects (circled in yellow), represented by
the (A) histone channel, (B) vimentin channel, and (C) CD45 channel. (D) Pseudo flow plot showing
signal intensities of E-cadherin, Collagen I, CD45RO and CD3 against the histone channel before
and (E) after removal of nonspecific high intensity cells.

104

Figure 3.4. Expression profiles of annotated cell types by pseudo flow plots
(A) Validation of tissue type cells (ASMA+ cells (dark pink), epithelial cells (green), NCAM (yellow),
and other stromal cells (lilac)). (B) Validation of CD4+ T cells (salmon), CD8+ T cells (light blue),
and regulatory T cells (purple). (C) Validation of CD20+ B cells (pink), plasma cells (blue). (D)
Validation of myeloid cells CD11b+ cells (light orange), CD14+ monocytes (red), CD16+ myeloid
cells (green), CD68+ macrophages (blue).
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Figure 3.5. Validation of cell type annotation by pseudo color overlay images
(A) Validation of tissue cell types (epithelial cells, ASMA+ cells, NCAM, and stromal cells), (B) T
lymphocytes (CD8+ T cells, CD4+ T cells, and regulatory T cells), (C) B lymphocytes (CD20+ B cells
and plasma cells), and (D) myeloid cells (CD68+ macrophages, CD14+ monocytes, and CD11b+
myeloid cells). Cells that correspond to cell type of interest are circled in yellow.
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Figure 3.6. Segmented cells were annotated into 13 cell types based on protein expression
(A-C) tSNE plots colored by expression of (A) E-cadherin, (B) Vimentin, and (C) CD45 show that
mucosal cells can be categorized into three cell types: epithelial, stromal, and immune cells,
respectively. (D) Heatmap representing expression profiles of the 13 cell populations. The heatmap
colors represent average expression of a given marker for each cell population. (E) Bar graph
showing distribution of cell types across patient samples.
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Figure 3.7. tSNE plot based on expression of the markers from the IMC antibody panel
Colors represent the 13 annotated cell populations.
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Figure 3.8. H&E images of histopathological features observed in the study
Images were assessed for presence of (A) neutrophil infiltration, (B) crypt abscesses, (C) crypt
distortion, and (D) pyloric metaplasia. Asterisks mark the histological features.
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Figure 3.9. Pseudo color overlay and H&E images of fibrosis
(A, B) Control colon sample shows normal epithelial crypt structure and a thin layer of muscularis
mucosae at the base of the tissue. (C, D) Ulcerative colitis sample without no fibrosis. (E, F)
Ulcerative colitis sample with increased collagen deposition in the lamina propria and thickening of
the muscularis mucosae. A, C, and E are pseudo-color overlay images generated by IMC, and B,
D, and F are H&E images from adjacent sections.
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Figure 3.10. IBD epithelia exhibit increased proliferation and HLA-DR expression
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(A) Boxplot showing the rate of proliferation quantified by calculating the proportion of epithelial
cells that are Ki67-positive. Each point represents a single image, and each point type represents
a patient sample. (B-E) Representative IMC overlay images of Ki67+ epithelial cells for the four
disease groups. (F) Boxplot showing median expression of E-cadherin and HLA-DR. (G-J)
Representative IMC overlay images of HLA-DR expression for the four disease groups. Not
significant (ns), Q > .05, (*) Q < .05, (***) Q < .001, (****) Q < .0001.
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Figure 3.11. H&E images corresponding to IMC overlay images from Figure 2 and Figure 4
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(A) Control ileum image corresponding to Figures 2B and 2D, and 4D and 4E (first column); (B)
Crohn’s disease image corresponding to Figures 2C and 2H, and 4D and 4E (second column); (C)
Control colon image corresponding to Figures 2D and 2I, and 4D and 4E (third column); (D)
Ulcerative colitis image corresponding to Figures 2E and 2J, and 4D and 4E (fourth column). Black
boxes represent the zoomed in images shown the right.
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Figure 3.12. Epithelial proliferation and HLA-DR median expression by inflammation grade
(A) Epithelial proliferation, (B, top) median expression of E-cadherin, and (B, bottom) median
expression of HLA-DR. Plots labeled ‘ileum’ contain data from CI and CD, and plots labeled ‘colon’
contain data from CC and UC. Each point represents an individual image acquired by IMC. Lines
connecting two points indicate images that came from the same patient but were assigned different
116

inflammation grades. If more than one image represents a single patient sample in a given
inflammation grade, the line meets at the mean value of those images.
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Figure 3.13. Immune cell composition in the IBD mucosa
For each image, immune cell composition was quantified as a proportion, based on the number of
cells of a specific cell type out of the total number of cells captured in the image. (A) Boxplots
showing frequency of individual immune cells by image and disease: (top) CD4+ T cells, CD8+ T
cells, CD68+ macrophages, (bottom) CD14+ monocytes, plasma cells, and Tregs. Each point
represents a single image, and each point type represents a patient sample. (B) Heatmap showing
hierarchical clustering of 48 images based on their immune cell composition profiles. The
118

proportions were normalized by z-score for visualization. Not significant (ns), Q > .05, (*) Q < .05,
(***) Q < .001, (****) Q < .0001.
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Figure 3.14. Boxplots of immune cell composition by grades of inflammation
Plots labeled ‘ileum’ contain data from CI and CD, and plots labeled ‘colon’ contain data from CC
and UC. Each point represents an individual image acquired by IMC. Lines connecting two points
indicate images that came from the same patient but were assigned different grades of
inflammation. If more than one image represents a single patient sample in a given inflammation
grade, the line meets at the mean value of those images.
121

Figure 3.15. Activated CD68+ macrophages and CD8+ T cells are increased in IBD
(A) Heatmap showing hierarchical clustering of 48 images based on abundance of CD68+
macrophage and CD8+ T cell subsets. The proportions were normalized by z-score for visualization.
(B) Boxplots of the proportion of CD38+ CD8+ T cells, CD69+ CD8+ T cells, and Granzyme B+ CD8+
122

T cells by image and disease group, (C) Boxplots of the proportion of Granzyme B+ CD68+
macrophages and Lysozyme C+ CD68+ macrophages by image and disease group. Each point
represents a single image, and each point type represents a patient sample. (D) Representative
IMC overlay images of Granzyme B+ CD68+ macrophages, and (E) Lysozyme C+ CD68+
macrophages for each disease group. Regions with double positive cells are marked by yellow
asterisks. Not significant (ns,) Q > .05, (*) Q < .05, (***) Q < .001, (****) Q < .0001.
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Figure 3.16. Neighborhood analysis shows more enrichment of immune cells surrounding
Tregs in CD than UC
(A) Diagram comparing enrichment of immune cell types neighboring Tregs. Plasma cells, CD4+ T
cells, and CD68+ macrophages are enriched in both CD and UC while CD14+ monocytes and CD8+
T cells are only enriched in Treg neighborhoods in CD. (B) Diagram comparing enrichment of active
immune cell subsets in Treg neighborhoods shows that Lysozyme C+ CD68+ macrophages are

124

enriched in Treg neighborhoods compared to non-active counterparts in CD but not UC. (C)
Statistical significance of Treg-immune cell interactions. Created with BioRender.com.
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Figure 3.17. Boxplots of CD68+ macrophage and CD8+ T cell subsets by grades of
inflammation
The left column labeled ‘ileum’ contains data from CI and CD, and the right column labeled ‘colon’
contains data from CC and UC. Each point represents an individual image acquired by IMC. Lines
connecting two points indicate images that came from the same patient but were assigned different
grades of inflammation. If more than one image represents a single patient sample in a given
inflammation grade, the line meets at the mean value of those images.
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CHAPTER 4. CONCLUSION
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SUMMARY
In Chapter 2, I investigated the role of WNT5A produced by FOXL1+ mesenchymal cells in
establishing epithelial cell polarity during embryonic development by deriving a FoxL1-Cre; Wnt5af/f
mouse model for conditional ablation of WNT5A in FOXL1+ cells. I hypothesized that WNT5A
deletion would disrupt epithelial structural integrity, specifically by loss of apical-basal polarity and
increased apoptosis, thereby leading to a shortened gut phenotype. My data showed that although
intestinal structure and epithelial cell polarity were normal in FoxL1-Cre; Wnt5af/f mice, epithelial
cell apoptosis was increased at E12.5 during midgut elongation. I concluded that this increased
rate of epithelial apoptosis caused a shorter intestine of the mutant mice at birth. Interestingly,
midgut shortening in FoxL1-Cre; Wnt5af/f mice was not as severe as had been described in WNT5A/-

mice, where completely WNT5A deficient mutant mice had an 80% reduction in midgut length on

day 18.5 of gestation (Cervantes et al., 2009), while in the model I developed, I observed only a
20% reduction compared to controls. However, a major limitation of the prior study utilizing WNT5A/-

mice is that because it is a global deletion, it is not clear whether the severe gut shortening is an

indirect consequence of the generalized growth defect of these mice (Yamaguchi et al., 1999). My
study highlighted the importance of utilizing cell-type specific gene ablation mouse models to
assess the function of WNT5A – or any other signaling molecule – to eliminate the effects that
whole-body mutation may have on the intestine. Thus, this study was significant because it was
the first to identify a specific cell type as a source of WNT5A to regulate intestinal development.
Human intestinal diseases such as IBD are still being actively pursued in the translational
research space because there are still large unmet needs for patients who do not respond well to
currently available therapies, and because the exact mechanisms of disease pathogenesis remain
elusive. In Chapter 3, I shifted my research focus to directly studying human intestinal disease
using a novel methodology that had never been applied to the tissue before; specifically, I
developed a multiplexed tissue staining and image analysis pipeline to characterize the cellular
profiles of IBD tissues using limited proteomics with spatial resolution. I showed that (1) the
epithelial proliferation rate and expression of HLA-DR, a class II major histocompatibility complex
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protein critical to antigen presentation, are increased in IBD samples and are correlated with
inflammation severity, (2) immune cell composition profiles of the IMC images correlate not just
with disease but with the specific type of inflammation, and (3) there are more immune cell
populations enriched in Treg neighborhoods in Crohn’s disease than in ulcerative colitis. The study
was significant because I developed an antibody panel, staining protocol, and analysis pipeline for
performing numerous assessments of the cellular profile of IBD tissues, which could ultimately be
used for improving disease stratification and identifying novel therapeutic biomarkers. Specifically,
IMC may be beneficial for identifying subpopulations of IBD patients based on age of disease onset,
inflammation location, clinical symptoms and severity, and response to therapy.
In this final chapter, I will discuss some of the limitations and challenges that I faced in
each study. I will conclude with final insights on how novel technological advancements may shape
our future understanding of intestinal development, homeostasis, and disease.
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WNT5A STUDY: CHALLENGES, LIMITATIONS, AND FUTURE PERSPECTIVES

Challenges of studying non-canonical Wnt signaling in mouse intestinal development
While canonical Wnt signaling has been studied extensively for the identification of specific
Wnt ligands, receptors, effectors, and nuclear factors involved, non-canonical Wnt signaling is
much more expansive and therefore the exact pathways and functions of non-canonical Wnt
signaling largely remain elusive. One of the biggest challenges to better understanding the noncanonical pathway(s) is that many of the signaling cascades and downstream targets are nontranscriptional, involving cytoskeletal rearrangements and protein trafficking within the cytoplasm
and to and from the cell membrane to establish cell polarity (van Amerongen, 2012). Thus,
performing transcriptomic studies, which are relatively easy to perform, cannot directly reveal the
mechanisms by which cell polarity is established.
Furthermore, the nuclear factors known to be involved in non-canonical Wnt signaling are
cJUN and NFAT, which unfortunately both promote transcription of numerous genes to activate a
broad range of context-dependent cellular activities (Dejmek et al., 2006; Oishi et al., 2003). Due
to these challenges, most studies investigating the mechanisms of cell polarity resort to visualizing
the localization of cell polarity proteins by immunohistochemistry (IHC), and consequently this was
the main assay used in my study in Chapter 2. However, utilizing IHC is limiting because it only
allows for staining 1-3 proteins per section, and many proteins that contribute to Wnt signaling
(including FOXL1 and WNT5A) are so lowly expressed that signals are difficult to detect by this
methodology. Future studies will have to rely on development of more advanced technologies for
assessing multiple proteins and their interactions at a subcellular resolution.

Heterogeneity of mesenchymal cell populations expressing WNT5A
I investigated the role of FOXL1+ mesenchymal cells in WNT5A production during intestinal
development and showed that ablating WNT5A in these cells is sufficient to generate a shortened
gut phenotype. However, in situ hybridization of Foxl1 and Wnt5a showed that these genes do not
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overlap completely in the developing intestine, as shown in Figure 2.1. In fact, while Foxl1 was
localized strictly along the sub-epithelium, Wnt5a was more broadly expressed within the gut
mesenchyme. The implication of this finding is that FOXL1+ mesenchymal cells are not the only
source of WNT5A during midgut elongation, and there is still a need to identify a gene marker that
could drive deletion of all WNT5A proteins in the embryonic intestine without the use of a global
null mice. Recent studies have identified several markers of mesenchymal cells that support the
intestinal stem cell niche, such as CD34 and GLI1 (Degirmenci et al., 2018; Greicius et al., 2018;
Shoshkes-Carmel et al., 2018; Stzepourginski et al., 2017; Vannucchi et al., 2013). These CD34+
cells, GLI1+ cells, and FOXL1+ cells are not mutually exclusive, but even a combination of these
cell type markers may only cover a subset of mesenchymal cells that produce WNT5A during
development. Ultimately, a deeper transcriptomic assessment of the mesenchymal cells by single
cell RNA-seq would be required. However, because mesenchymal cells are large and fragile, it is
challenging to generate whole cells from the intestine to perform single cell RNA-sequencing. This
limitation could be circumvented by isolating whole nuclei and performing single nuclear RNAsequencing, which is a method commonly used in neuroscience research to generate
transcriptomic profiles of neurons (Mo et al., 2015). Other platforms to consider for better defining
mesenchymal subpopulations re spatial-omics technologies, which I describe in more detail later
in this chapter.
Because the molecular processes involved in intestinal development are highly dynamic,
the mechanisms driving Wnt5a expression in mesenchymal cell populations may be changing at
every embryonic stage. For example, I saw that while Wnt5a is more broadly expressed than Foxl1
within the mesenchyme during E12.5 and E14.5, by P0 Wnt5a expression becomes restricted to
the sub-epithelium and becomes more co-localized with Foxl1. Thus, one limitation to this study
was the fact that I only assessed the role of FOXL1+ cell-derived WNT5a at only three
developmental stages: E12.5, E14.5, and P0. By omitting all the embryonic stages in between, I
also omitted the investigation of the role of FOXL1+ cell-derived WNT5A in mesenchymal cluster
formation and villus formation, as well as the switch from canonical Wnt-independent to canonical
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Wnt-dependent mechanisms of epithelial proliferation that occurs around E16.5 in the mouse.
Thus, future studies should incorporate more embryonic time points spanning both prenatal and
neonatal periods for a more detailed understanding of the role of FOXL1+ cells in intestinal
development.
Finally, there are several non-canonical Wnt proteins that are expressed in the developing
intestine, such as Wnt7 and Wnt11 (Lickert et al., 2001), and these non-canonical Wnt proteins
may have overlapping functions during midgut elongation. In my study, I focused only on Wnt5a
and did not assess the potential compensatory mechanisms of FOXL1+ cells to overexpress these
other non-canonical Wnt ligands. In the future, it would be interesting to conduct the same study
but using either Foxl1-Cre; Porcnf/f mice to ablate function of all Wnt ligands, or deriving Foxl1-Cre;
Wnt5af/f; Wnt5bf/f; Wnt11f/f mice crossed to several non-canonical Wnt loxP alleles to ablate only
non-canonical Wnt ligands, to see a more drastic effect of ablating Wnt signals from FOXL1+ cells.
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IBD STUDY: CHALLENGES, LIMITATIONS, AND FUTURE PERSPECTIVES
Limitations in research scope
The study in Chapter 3 utilized human biopsy sections to characterize the cellular profiles
of IBD. Using human samples is critical for the study of human disease, because IBD is
multifactorial and findings from mouse models are not completely translatable to humans. However,
some limitations from my study included having a small cohort size and not having access to more
detailed patient clinical data.

Small cohort size
Patient sample sections used in this study were procured from the Children’s Hospital of
Philadelphia. We obtained six Crohn’s disease ileitis samples, six healthy control ileum samples,
six ulcerative colitis samples, and six healthy control colon samples for a total of 24 tissue samples
to be analyzed using the IMC. Although the main goal of my study was to develop an antibody
panel, staining protocol, and analysis pipeline for IMC and demonstrate the power of multiplexed
image analysis for IBD tissues, the goal of this study was not solely technology development but
also aimed to gain new insights into disease pathogenesis. From the beginning, I was aware of the
high variability inherent to small cohort observational studies and attempted to take appropriate
measures to mitigate these issues. First, I utilized appropriate statistical testing methods in all the
analyses. The IMC data was fitted using a generalized linear mixed model (GLMM) which
considered three random effect terms: cell-specific, image-specific, and patient-specific, and used
the maximum likelihood ratio test to determine statistical significance between disease and control
groups. Furthermore, p values were adjusted for multiple comparisons using the BenjaminiHochberg method (Benjamini & Hochberg, 1995). Finally, because my study was largely a
technology-development study, it was especially important that findings of previous literature were
confirmed. I aimed to perform proof-of-concept analyses with IMC so that we can be more confident
about the use of IMC for future larger human studies.
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Limited patient clinical data
Another limitation to this study was that because the patients for which we were given
biopsy tissue had not been consented in advance for the explicit purpose of IMC analysis, I did not
have access to patient clinical data other than age, sex, diagnosis (CD or UC), and disease
duration. Because IBD is a highly heterogeneous disease with a wide range of age onset,
inflammation presentation, and pathophysiological feature, incorporating additional patient
information to the analyses could have improved the types of comparative analyses that could be
performed, such as patients’ treatment course or lack thereof, and differences in clinical
presentations. Additionally, knowing the status of active and/or inactive disease at the time of
biopsy would have improved the study for more in-depth characterization of immune cell
composition and activity. Regardless, I believe that these limitations did not take away from the
overall significance of the study to successfully develop IMC for deep characterization of human
IBD tissues.

Technical challenges of IMC
There are several limitations to consider when using the IMC. First, because staining for
IMC does not allow for multiple amplifications for antibody detection, the technology is not suitable
for detecting lowly expressed antigens such as cytokines and transcription factors. In my study, I
was unable to include antibodies to differentiate between T helper cell subsets such as Th1 and
Th2, which are especially important for Crohn’s disease and ulcerative colitis pathogenesis,
respectively. Regardless, I believe the countless biological questions that could be answered by
IMC analysis outweighs these challenges in antibody panel generation.
Second, in many of the images acquired in my study, I observed high, nonspecific signals
around tissue edges. This is a phenomenon often seen in immunofluorescent staining methods,
which are frequently termed “edge effects”. As a result, I often observed signal intensity
inconsistencies within single IMC-acquired images. I also observed variability in signal intensities
across all the images in the study due to the technical variabilities of helium and argon gas pressure
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passed through the imaging mass cytometer, as well as the UV ablation voltage that changed over
time. To mitigate these variabilities, I took several quality control measures such as removing tissue
regions with edge effects, and even removing an entire image altogether because the overall signal
intensities of all channels in this image was inconsistent from the rest. Furthermore, other than Ecadherin and HLA-DR channels which had comparable signal intensity distribution across all
images, for all other channels I chose to eliminate quantitative expression level analysis based on
signal intensity values, and instead analyzed cell composition and activity based on proportion of
cellx expressing specific marker combinations. I acknowledged that biologically, protein expression
does not operate in an “on” and “off” modality; however, I determined that removing as much
technical variability from the analysis as possible was essential to generate reliable results.
Despite these limitations, there are also many advantages of IMC. For example, IMC is an
imaging platform combining both mass cytometry and immunohistochemistry techniques to yield
multi-channel images of 30+ protein markers (Giesen et al., 2014; H. A. O. Wang et al., 2013). I
generated an antibody panel of 31 markers for epithelial cells, stromal cells, and mucosal immune
cells which were then used to stain 24 paraffin-embedded intestinal tissue sections of IBD and nonIBD patients. In the end, I was able to segment and annotate almost 400,000 cells to be used for
downstream protein expression, cell composition, and cell-to-cell interaction analyses.
IMC is a much more improved platform for image analysis than standard IHC. First,
because IMC uses lanthanide earth metal masses to quantify signal intensities of each antibody,
the system eliminates bleed-through of partially overlapping emission/excitation spectra of
fluorophores. Second, the ability to visualize more than 30 proteins on a single histological section
has many advantages over previously established staining methods such as IHC, where staining
is limited to 1-3 markers at a time. For example, incorporation of E-cadherin, ASMA, and vimentin
antibodies allows us to visualize the mucosal environment of each tissue section; on top of that,
incorporation of numerous immune cell markers allow us to analyze tissue-specific compositions
of these immune cells. Finally, neighborhood analysis for quantifying cell-to-cell interactions of
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immune cells requires the incorporation of multiple protein markers, which is not possible by IHC.
As a result, such spatial analyses are simply not possible using standard IHC methods.

Limitations due to lack of standardized image analysis methods
My study aimed to introduce a novel technology to the IBD field and highlight the IMC’s
potential to be a powerful tool in translational and drug development research. However, one of the
biggest challenges of my thesis work was developing an analysis pipeline from limited published
resources. IMC was introduced less than a decade ago (Giesen et al., 2014); thus there is still a
lack of widely accepted methods by which images are segmented, normalized, and annotated, and
the manufacturer of the instrument has not developed a universally accepted analysis pipeline.

Segmentation
The use of IMC in literature has more than doubled in the past 5 years; yet these studies
use a variety of cell segmentation software, including Cell Profiler (Kamentsky et al., 2011) and
Ilastik (Sommer et al., 2011), EBImage (Pau et al., 2010), and many other segmentation methods
developed in-house (Batth et al., 2020; Chang et al., 2016; Warren et al., 2020). However, in more
recent years, pixel classification by machine learning using Cell Profiler and Ilastik has become the
most widely used method for performing cell segmentation on IMC images. Ilastik is an opensource software which uses machine learning to learn segmentation features using a random forest
classifier (Sommer et al., 2011). Using Cell Profiler and Ilastik also enables the use of both cell
membrane markers and nuclear markers to predict individual cell surfaces.
Despite the benefits of machine learning methods to improve cell segmentation accuracy,
I chose cell segmentation using the pixel expansion method (See Chapter 3 Materials and
Methods) using Vis software (Visiopharm). I used the nuclear channel (Iridium 191 and 193) as
input and used a polynomial local linear image processing step to identify round objects in the
image. I relied on the signal intensities of the Iridium channel to distinguish individual nuclei, as well
as the E-cadherin channel to distinguish nuclei within the epithelium. After these initial steps, I
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expanded the nuclear mask by 3 pixels to estimate cell surface. While the pixel expansion method
covers larger cells such as epithelial cells and macrophages only partially, I chose this method over
machine learning as this method worked best to minimize signal contamination from adjacent,
closely spaced cells.

Data normalization
There is currently no standardized way of normalizing IMC data; therefore, investigators
have employed many different data normalization methods to unify the dataset across all images,
including arcsinh transformation (Giesen et al., 2014; Li et al., 2019), z-score normalization
(Bouzekri et al., 2019; Park et al., 2019), 99th percentile normalization (Damond et al., 2019; Durand
et al., 2019), log transformation (Schulz et al., 2018; Y. J. Wang et al., 2019; Warren et al., 2020),
dividing by median histone signal (Batth et al., 2020), and omitting normalization (Singh et al.,
2019). Additionally, methods for cell type annotation from these studies vary from clustering,
manual gating, PhenoGraph (Levine et al., 2015), to Ilastik object classification. In my study, I chose
to not normalize the data and instead used the raw mean signal intensities of all channels of all
cells. The rationale was that if cell type composition is heterogenous across different images,
normalizing data can skew signals in ways that can affect the downstream analyses. Instead, to
account for even the slightest shift in signal distribution between one acquisition session to another,
I (1) performed cell type annotation by manual thresholding of each channel of each image, and
(2) avoided performing expression level analyses using continuous expression variables. Instead,
most of my analyses quantify proportion based on binary expression, i.e. whether or not a cell
expresses a certain marker protein.
It is likely that the use of different analysis methods described above can lead to different
outcomes of the same data; thus, IMC studies that use different methodologies cannot be crosscompared. As spatial-omics become more widely accessible for basic and translational research,
standardized methods for cell segmentation, data normalization, and cell type annotation will need
to be established for generating reproducible results. Until this happens, studies should incorporate
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proof-of-concept analyses by recapitulating previous findings within their field so that any novel
findings generated from their analyses are also reliable. Furthermore, novel findings from imaging
platforms should be validated on a different platform.

Advancements in multiplexed imaging and spatial analysis platforms
Despite these challenges, multiplexed imaging platforms are continuing to expand the
ways in which scientists can address biological questions by incorporating spatial information, and
we have seen advancement of multiplex imaging platforms as more and more researchers move
into this exciting space. Since the first IMC study was published in 2014 (Giesen et al., 2014), there
has been a large expansion in novel spatial proteomics and spatial transcriptomics platforms that
are being used to study human diseases. Similar to IMC, multiplexed ion beam imaging (MIBI)
quantifies protein levels via signal intensity of metal-conjugated antibodies which are read by a
time-of-flight mass cytometer (CyTOF) (Angelo et al., 2014). Co-detection by indexing (CODEX)
was developed in 2018 for multiplexed imaging using barcoded antibodies which are imaged by
cycling 3 reporter dyes at a time (Goltsev et al., 2018; Schürch et al., 2020). Furthermore, spatial
transcriptomics platforms such as Visium (10X Genomics), MERFISH (Vizgen), and Geomx DSP
(Nanostring) are now commercially available and have some improved features compared to IMC.
For example, MERFISH allows for in situ hybridization detection of more than 1,000 different
transcripts which can be quantified for copy number mRNAs at a subcellular resolution (Chen et
al., 2015). As multiplexed imaging platforms evolve, so will human disease research in early
discovery and clinical phases. Future IBD studies that take advantage of spatial-omics may
consider these more novel and advanced platforms that would be best suited for the research
question at hand.

Advancing IBD research using IMC
One of the main challenges in understanding IBD is the availability of a disease model that
accurately recapitulates IBD phenotype. As discussed in Chapter 1, while there are several mouse
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models available for in vivo studies, some results obtained using these mouse models is not directly
translatable to human IBD (Pizarro et al., 2019). Therefore, it will be essential for future studies to
utilize more patient samples and apply reverse translational approaches to better understand IBD
mechanisms. Specifically, there needs to be a much deeper characterization of the mucosal
environment and the cell-to-cell interactions involved in both healthy and inflamed tissues to
elucidate the mechanisms of an overaggressive immune response, as well as dysregulation of
epithelial barrier function and wound repair. Addressing this can be challenging because human
tissue samples are not as readily available as mouse tissues, and biopsies are not performed
frequently enough in each patient to allow for precise longitudinal tracking. To this end, highly
multiplexed platforms such as IMC could help address this issue because it allows numerous
histological assessments using just one tissue section and therefore maximizes the use of precious
biopsy samples. Thus, IMC is an excellent tool for improving disease stratification for IBD patients.
IMC could prove to be an even more powerful tool when combined with other genomic
platforms in a multi-omics approach. Incorporation of multiple genomics platforms – such as single
cell RNA-seq to investigate the transcriptome, microbiome sequencing to determine bacterial
composition, and ChIP-seq, ATAC-seq, and DNA methylome analyses to characterize the
epigenome – promises to improve the power of the study to unravel pathways involved in IBD
pathogenesis. However, none of the tools commonly used in multi-omics studies have the ability to
retain spatial resolution, which is essential for identifying novel cell-cell interactions and spatially
resolved cellular activities. Thus, one could envision a scenario where a multi-omics approach is
used first to identify converging pathways and biomarkers that may explain mechanisms of disease,
and then IMC could be utilized for determining spatially resolved patterns of these pathways and
biomarkers. In summary, I believe that incorporating spatial resolution to characterize cell to cell
interactions within the IBD mucosa will be transformative in addressing the unmet needs for IBD
patients.
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CONCLUDING REMARKS
Undoubtedly, there is still so much we do not know concerning all areas of intestinal
biology, including development, homeostasis, and disease. To this end, this thesis addressed two
distinct areas of intestinal research. In Chapter 2, I studied intestinal development and the role of
signaling molecules emanating from mesenchymal cells in regulating epithelial structural integrity
using a genetic ablation mouse model, and in Chapter 3, I investigated human inflammatory bowel
disease tissues to uncover the cellular profiles of inflamed intestinal mucosa that are common to
or different between Crohn’s disease and ulcerative colitis. These two areas of intestinal research
together highlight the importance of understanding normal intestinal processes in order to improve
our understanding of diseases like IBD.
A critical feature of IBD patients is a weakened epithelial barrier function. This can be
caused by a combination of factors including genetic risk loci, dietary intolerance, unfavorable
microbiome, and an overactive immune response, but mouse studies have shown us that
dysregulation of epithelial barrier function by itself can lead to colitis. In Chapter 2, I aimed to better
understand how epithelial structural integrity is established during development, by genetically
ablating WNT5A in FOXL1+ mesenchymal cells in mice during fetal development. Although we
know that mouse models are not directly translatable to IBD, studies like the one in Chapter 2 can
lead to new ideas in intestinal disease research. For example, given what we know about FOXL1+
mesenchymal cells in development and in homeostasis, we could speculate that these cells may
play a role in epithelial barrier function and wound repair mechanisms in adult intestines. Thus, it
may be of great interest for future studies to characterize the role of human FOXL1+ cells in IBD
pathogenesis. Especially as multiplexed imaging and spatial omics platforms continue to advance,
it will be fascinating to see how these tools will be implemented for improved understanding of
intestinal regulation.
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